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Functionalization of metal oxide nanoparticles enables their use in biological 
applications via hybridization of biological molecules and modification of surface 
properties.  This Ph. D research is aimed at increasing knowledge of the process of 
metal oxide nanoparticle functionalization for biological applications.  The 
achievements presented in this dissertation can be divided into three categories: i) a 
fluorescence-based quantitative evaluation of surface coverage and bio-activity of 
antibodies immobilized on magnetic nanoparticles (MNPs), ii) differential 
functionalization of SiO2/TiO2 mixed nanoparticles via preferential binding of 
phosphonic acids to TiO2 and subsequent trimethyl silyl group binding to the 
remaining surface, and iii) X-ray scattering (XRS)-mediated detection of peak shifts 
of a biological substrate, Escherichia coli (E. coli), as a function of applied magnetic 
field strength and magnetic nanoparticle concentration in a cell growth medium. 
  
 In a study of MNP surface modification, quantitative evaluation of anti-mouse 
IgG binding on MNPs and bioactivity on MNPs was conducted via fluorescence 
assays.  Nanosize γ-Fe2O3 particles were hybridized with anti-mouse IgG via silane 
chemistry with 3-aminopropyltriethoxy silane and glutaraldehyde activation.  A 
chemisorption isotherm via fluorescence assays demonstrated that immobilization of 
anti-mouse IgG can be stoichiometrically controlled with the surface coverage at 
saturation corresponding to 36% of the theoretical limit.  The immobilized anti-IgG 
retains ~50% of its bioactivity at saturation.   
 Differential functionalization of SiO2/TiO2 mixed nanoparticles was 
demonstrated via aqueous-phase preferential binding of phosphonic acids to TiO2 and 
subsequent binding of trimethyl silyl group to the remaining surface.  SiO2/TiO2 
mixed nanoparticles with three different mole ratios of Si/Ti together with pure SiO2 
and TiO2 nanoparticles were used in comparative XPS study of differential 
functionalization. Differential functionalization of metal oxide-metal oxide mixed 
nanoparticles demonstrated herein adds a route to multifunctional nanoparticles.   
An In situ XRS study of E. coli in applied magnetic fields up to 423 mT was 
performed.  Two peaks, a sharp peak at q = 0.528 Å-1 (1.189 nm) and a diffuse peak at 
q = 0.612 Å-1 (1.027 nm), were detected in XRS of MNP-absent E. coli culture.  The 
presence of SiO2/γ-Fe2O3 MNPs at 40 mg/L in E. coli growth medium changes the 
sharp peak to the lower side of q as a function of applied magnetic field strength, 
while the position of the diffuse peak is invariable.  362 mT was found to be a critical 
magnetic field strength, at which the sharp peak disappears.  This study demonstrates 
magnetic field-assisted interactions between E. coli cell membranes and MNPs.    
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Chapter 1: Introduction 
 
1.1 Motivation 
Nanosize metal oxide particles have emerged as versatile tools for biological 
applications due to their magnetic, electronic, photonic and optical properties.  
Surface modification of metal oxide nanoparticles adds to the usefulness of the 
nanoparticles on top of their intrinsic characteristics, since hybridization of functional 
molecules on the nanoparticles provides target-specific recognition, catalytic abilities, 
and controlled surface properties such as hydrophobicity.  Assemblies of metal oxide 
nanoparticles and biomolecules such as antibodies, enzymes, and streptavidin via 
surface modification of the nanoparticles have drawn a growing interest in the areas 
of bioanalysis and fabrication of bioelectronic devices.1, 2  A quantitative evaluation 
of biomolecule hybridization with nanoparticles is desired, since it will lead to a 
better control of nanoparticle-biomolecule assemblies.       
Multifunctional nanoparticles have promising potential in biological 
applications, especially in cancer-specific applications as drug carriers and imaging 
agents, because they multitask, overcoming biological barriers, targeting specific 
cancer cells and delivering drugs.3  Multiplexed nanoparticles such as metal-metal4, 5 
and metal-metal oxide3 nanocomposites have been applied as multifunctional 
nanoparticles via differential surface modification.  Differential surface modifications 
of SiO2-TiO2 surfaces,6-8 via the preferential binding of phosphonates to TiO2 and 
subsequent binding of  poly(L-lysine)-g-poly(ethylene glycol) or trimethyl silyl 
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groups (-OSi-(CH3)3) to SiO2,open the possibility to develop multifunctionality on 
SiO2/TiO2 mixed nanoparticles9 synthesized in our group.  
The ever increasing number of biological applications of metal oxide 
nanoparticles, especially magnetic iron oxide nanoparticles, requires a better 
understanding of the interactions between biological cells and nanoparticles.  X-ray 
scattering (XRS) provides a useful tool for detection of the interactions between 
cellular membranes and magnetic nanoparticles, since XRS has been employed in 
measurement of layer separation of biomimetic phospholipid layers.10  
 
1.2 Objectives 
This research is aimed at biological applications of metal oxide nanoparticles, 
specifically γ-Fe2O3 nanoparticles and SiO2/TiO2 and SiO2/ γ-Fe2O3 mixed 
nanoparticles.  Surface modification of the metal oxide nanoparticles via silane 
chemistry plays a crucial role in hybridizing anti-mouse IgG on γ-Fe2O3 nanoparticles.  
A quantitative evaluation of surface coverage and bioactivity of the γ-Fe2O3 
nanoparticle-anti-mouse IgG assembly is provided via fluorescence characterization 
of the dye-labeled anti-mouse IgG.  Differential functionalization of SiO2/TiO2 mixed 
nanoparticles is achieved via preferential binding of phosphonic acids on TiO2 and 
subsequent reaction with a mild silylating reagent.  Various characterization methods 
including X-ray photoelectron spectroscopy, Fourier transform infrared spectroscopy, 
fluorescence spectroscopy, and fluorometer measurement of emission from dye-
labeled antibodies along with electron microscopy are used to characterize the 
particle surfaces before and after surface modifications.  XRS is used to detect the 
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interactions between E. coli cellular membranes and SiO2/ γ-Fe2O3 mixed 
nanoparticles as a function of applied magnetic field strength, concentrations of the 
magnetic mixed nanoparticles and divalent ions in the cell growth medium.     
 
1.3 Overview 
An overview of each chapter is presented as follows: 
 
Chapter 2–Background 
This chapter contains a literature review of the following three topics: i) 
generation of nanosize Fe3O4, Fe2O3, SiO2, and TiO2 particles and their 
nanocomposites such as Fe3O4-Au (or Ag) and SiO2-Fe2O3 composite particles via 
solution methods and aerosol synthesis, ii) ligands used to modify the surface of the 
metal oxide nanoparticles, and iii) E. coli cell membranes and X-ray scattering.  The 
section on solution phase synthesis of metal oxide nanoparticles and nanocomposites 
describes recent advances in the synthesis of the nanoparticles including iron oxide, 
titania, silica and metal oxide-noble metal composites.  The aerosol synthesis portion 
focuses mainly on the generation of metal oxide-metal oxide nanocomposites such as 
SiO2/TiO2 and SiO2/Fe2O3 composite nanoparticles.  Ligands used for surface 
modification of the metal oxide nanoparticles are reviewed including silanes, 
carboxylates, and diols.  Differential modifications of SiO2-TiO2 mixed surfaces are 
described focusing on the preferential binding of phosphonates to TiO2 surfaces.  The 
last part of this chapter is allotted for a brief description of E. coli cell membrane 
structures and X-ray scattering as a detection method of crystalline structures.    
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Chapter 3- Magnetic iron oxide nanoparticles for bio-recognition: Evaluation of 
surface coverage and activity 
This chapter describes a quantitative evaluation of anti-mouse IgG binding on 
γ-Fe2O3 nanoparticles via silane chemistry and glutaraldehyde activation.  A 
quantitative understanding of the anti-mouse IgG coverage of the magnetic 
nanoparticles (MNPs) and the bio-activity of the immobilized anti-mouse IgG is 
provided via measurements of fluorescence spectra of the dye-labeled anti-mouse 
IgGs and mouse IgGs.  The results demonstrate that loading of anti-IgG on the MNPs 
can be stoichiometrically adjusted with ~36% saturated surface coverage of the 
theoretical limit and the immobilized anti-IgG retains ~50% of its bioactivity at 
saturation.   
 
Chapter 4- Differential functionalization of SiO2/TiO2 mixed nanoparticles: an X-ray 
photoelectron spectroscopy study 
This chapter describes differential functionalization of aerosol-phase 
synthesized SiO2/ΤiΟ2 mixed nanoparticles.  Differential functionalization of the 
mixed metal oxide-metal oxide nanoparticles is achieved via preferential binding of 
phosphonic acids to TiO2 in aqueous solution and subsequent trimethyl silyl group-
binding to the remaining SiO2 surface.  An X-ray photoelectron spectroscopy study 
demonstrates the preferential binding of phenyl phosphonic acids to TiO2 of the 
mixed nanoparticles and ~80% retention of bound phenyl phosphonic acid following 
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trimethyl silyl group binding to SiO2.  Binding characteristics as a function of 
different mole ratios of Si to Ti are discussed.  
 
Chapter 5- X-ray scattering study of the interactions between magnetic nanoparticles 
and living cell membranes 
 This chapter describes an X-ray scattering (XRS) study of the interactions 
between E. coli cell membranes and magnetic SiO2/γ-Fe2O3 mixed nanoparticles in 
magnetic fields.  In situ X-ray scattering study of E. coli in the presence of magnetic 
fields up to 423 mT displays two peaks, a sharp peak at q = 0.528 Å-1 (1.189 nm) and 
a diffuse peak at q = 0.612 Å-1 (1.027 nm).  Addition of SiO2/γ-Fe2O3 mixed 
nanoparticles at a concentration of 40 mg/l of growth medium changes the sharp peak 
to the lower side of q, while the position of the diffuse peak is invariable.  362 mT is 
found to be a critical magnetic field strength, where the sharp peak disappears.  
 
Chapter 6-Conclusions and recommendations 
 This chapter contains conclusions and recommendations for future studies.  
Surface modification of metal oxide nanoparticles, especially iron oxide nanoparticles 
and SiO2/ΤiΟ2 mixed nanoparticles, is summarized.  In situ XRS study of E. coli is 
also summarized as a function of applied magnetic field strength up to 423 mT, and 
added SiO2/γ-Fe2O3 mixed nanoparticles.  Based on the summarized results, 
recommendations for future studies are presented.  
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Chapter 2: Background 
 
 
2.1 Abstract 
This chapter contains a literature review of synthesis and applications of 
nanosize metal oxide particles, focusing especially on Fe2O3, Fe3O4, TiO2, SiO2 and 
their nanocomposites.  A brief overview is presented of the synthesis of these metal 
oxide nanoparticles via solution phase and aerosol methods.  Several functional 
compounds are discussed, focusing on their metal oxide-surface modification 
capabilities for biological, medicinal, and catalytic applications.   Multiplexed 
nanoparticles, such as metal oxide-metal and metal oxide-metal oxide 
nanocomposites that demonstrate potential for utilization as multifunctional 
nanoparticles via differential surface modifications, are described.  Cell membrane 
structures along with X-ray scattering as a detection method for the d-spacing of a 
crystalline structure are briefly described at the end of the chapter.    
 
2.2 Introduction 
Nanosize metal oxide particles, especially Fe2O3, Fe3O4, TiO2 and SiO2, have 
been of intense interest due to their characteristic features such as electric, optical, 
magnetic, photo-sensitive properties.  In addition to their inherent characteristics, 
their amenability for surface modification has led to a great extension of their 
utilization in biological, medicinal and environmental applications.  Readily-available 
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functional groups including silanes, carboxylates, and diols have demonstrated 
capabilities for surface modification of these metal oxide nanoparticles.  Functional 
surface modifications of metal oxide nanoparticles have provided a number of tools 
for a construction of metal oxide nanoparticle-biomolecule hybrid systems, for 
example, iron oxide nanoparticle-antibody conjugates.1 
There is a great need for multifunctional nanoparticles in the areas such as 
magnetic resonance imaging (MRI), drug delivery and sensitive detection of 
pathogens.11  Multifunctional metal oxide nanoparticles have been constructed via the 
fabrications of metal oxide-metal3, 12  and metal oxide-metal oxide nanocomposites.6  
Differential surface modifications of metal oxide-metal oxide surfaces6-8 suggest the 
potential for the development of multifunctional metal oxide/metal oxide composite 
nanoparticles.     
 There is also a need for the investigation of the interactions between 
biological cell membranes and metal oxide nanoparticles for the purpose of 
enhancing understanding of the mechanisms of transport and for understanding 
chemical/physical interactions of the nanoparticles with cell membranes as drug 
carriers and cancer-treatment agents.  X-ray scattering is a useful tool for the 
detection of the interactions.13   
 This chapter is composed of the following sections: i) synthesis of Fe2O3, 
Fe3O4, TiO2 and SiO2 nanoparticles and their nanocomposites via solution phase and 
aerosol methods, ii) an overview of ligands for the surface modification of the metal 
oxide nanoparticles, iii) multifunctional metal oxide nanoparticles, focusing on metal 
oxide-metal oxide surfaces, and iv) E. coli cell membranes and X-ray scattering.  
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2.3 Generation of metal oxide nanoparticles 
2.3.1  Synthesis in solution 
Iron oxide nanoparticles:  Iron oxide nanoparticles have attracted much interest due 
to their useful characteristics including magnetic properties, biocompatibility and 
availability for surface modification.   
In the early 1980s, Massart developed a co-precipitation method of ferrous 
and ferric salts in alkaline and acidic aqueous phase to prepare Fe3O4 nanoparticles in 
the size range of 10-20 nm.14  The co-precipitation method has been used in many 
applications15-21 and also has been followed by efforts to improve the polydispersity 
by size fractionation after the co-precipitation step22-24.  Synthesis of monodisperse 
(standard deviation in size < 5%) iron oxide nanoparticles is highly desired in 
applications such as magnetic resonance imaging to enhance imaging capability.25, 26   
Recently, high-temperature decomposition of organic precursors led to the 
synthesis of monodisperse iron oxide nanoparticles.  Hyeon and collaborators27 
reported the synthesis of monodisperse γ-Fe2O3 nanoparticles with average diameters 
from 4 to 16 nm as a result of a careful control of the molar ratio of metal precursor to 
surfactant, Fe(CO)5 and oleic acid respectively. Amorphous monodisperse iron 
nanoparticles were first formed in their process and then were oxidized to 
nanocrystalline γ-Fe2O3 particles with a mild oxidant, trimethylamine oxide.  They 
further modified the methodology, thermolysis of the iron-oleate complex, as a source 
for ultra-large-scale synthesis of monodisperse nanocrystalline iron oxide particles, 
40 g in a batch.28  They were able to substitute the toxic and expensive organometallic 
compound, Fe(CO)5, with an environmentally benign and cost-effective reagent, 
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FeCl3·6H2O, in the metal-surfactant complex formation step.  They also investigated 
the mechanism of the nanocrystalline synthesis through analysis using transmission 
electron microscopy, infrared spectroscopy, thermogravimetric analysis, and 
differential scanning calorimetry.  According to their analysis results, the difference 
in temperature dependence between the rates of nucleation and particle growth is a 
key factor in synthesizing the monodisperse nanocrytalline metal oxides.  Sun and 
Zeng29 reported the synthesis of magnetite (Fe3O4) nanoparticles in high-temperature 
(265 OC) treatment of iron (III) acetylacetonate in phenyl ether in the presence of 
alcohol, oleic acid, and oleylamine.  4 nm size magnetite particles were synthesized in 
this process and larger magnetite particles up to 20 nm in diameter were made 
through a seed-mediated growth method.  In this approach, additional precursors are 
added to the 4 nm magnetite particles.    
The facile synthesis of monodisperse maghemite (Fe2O3) and magnetite 
nanoparticles via the methods including those mentioned above has led to an active 
application of the magnetic nanocrystallites in biological and medicinal areas through 
surface modification and fabrication of the nanoparticles.    
 
Silica nanoparticles: The Stöber process has typically been used to prepare spherical 
silica particles.30  The Stöber process involves hydrolysis of an alkoxy silane such as 
alkoxide tetraethoxysilane (TEOS) and silanol-condensation.  Silica-coatings in 
Fe2O3 core/shell structures have also been prepared using the Stöber process.31  In 
addition to the synthesis of spherical silica nanoparticles, Martin and collaborators32 
have demonstrated template-based synthesis of silica nanotubes.   
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Titania nanoparticles: TiO2 is a well-known and widely-used semiconductor 
material because of its photocatalytic property.  TiO2 has three phases: 
thermodynamically stable rutile, metastable anatase, and brookite.  Generally, anatase 
phase is found in crystalline TiO2 synthesized by the sol-gel and aerosol methods.  
Several preparation methods of TiO2 nanoparticles are available in the literature.  For 
example, hydrolysis of titanium (IV) alkoxides in aqueous and alcohol solvent led to 
TiO2 nanoparticles of three different sizes and phases: 0.7 nm (amorphous), 0.8-1.4 
nm (polycrystal-like), and 6.0 nm (polycrystal).33  Rajh and collaborators have 
synthesized nanocrystalline TiO2 in two steps: (i) dropwise addition of titanium (IV) 
chloride to cooled water, (ii) slow growth of the particles by dialysis until pH 3.5 was 
reached in the solution.34, 35  The synthesized TiO2 nanoparticles were 4.3 ± 0.4 nm in 
diameter.  Cozzoli et al.36 reported the synthesis of TiO2 nanocrystals by low-
temperature (80-100 OC) hydrolysis of titanium (IV) alkoxide in the presence of oleic 
acid as surfactant.    
 
Metal oxide-metal nanocomposites: Recent progress in the synthesis of metal-metal 
or metal oxide-metal composite nanoparticles has been reported.3, 12, 37-39  Figure 2.1 
summarizes the schemes for the attachment of Au (or Ag) nanoparticles on metal 
oxide nanoparticles.  
Metal oxide/Au (or Ag) nanocomposites were fabricated in several ways.  
Halas and collaborators have reported an application of the affinity between Au and 
the amine functional group to the fabrication of silica-gold nanoshells with tunable 
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optical properties.40-42  Gold nanoparticles were attached on amine groups of APTES-
modified silica core nanoparticles and a gold shell was grown along the attached Au 
nanoparticles in a subsequent treatment of HAuCl4.  The plasmonic characteristic of 
the dielectric silica core-gold shell structures was effective in inducing a thermal 
damage on carcinoma cells.  This approach was followed in the preparation of Fe3O4-
Au nanocomposites.43    
  12 
 
 
Organic 
droplet
Ag+
Ag+ Ag+
Ag+
Ag+
Ag+
Ag+
Ag+
Ag+
Aquous phase
Fe(CO)5 (i) decomposition
(ii) oxidation
APTES HAuCl4
= nanoparticle (Fe3O4, Au or FePt)
= Ag nanoparticle
SiO2 or Fe3O4
HAuCl4 (or AgNO3)/UV light
TiO2
Au
Fe3O4Au
(a)
(b)
(c)
(d)
   Au 
(or Ag)
Au
Si (CH2)3NH2
O
O
O =
 
 
Figure 2.1  Strategies to attach Au or Ag nanoparticles on metal oxide nanoparticles. 
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  Recent efforts have been directed to the development of heterodimeric iron 
oxide-metal nanocomposites.  The heterodimeric nanoparticles were synthesized in 
the following ways: i) metal oxide nanoparticle assembly at liquid-liquid interfaces 
and deposition and growth of Au (or Ag) on the metal oxide nanoparticles,3 ii) 
decomposition and oxidation of metal oxide precursor on the surface of Au 
nanoparticles.12  Xu and collaborators used nanoparticle assembly at a liquid-liquid 
interface to form heterodimeric nanoparticles, for example Fe3O4-Ag.3  Ag 
nanoparticles were seeded and grown on the surface of Fe3O4 nanoparticles (d= 8 nm) 
assembled at the interface between organic droplets and an aqueous phase (Figure 
2.1(d)).  Sun and collaborators12 also prepared heterodimeric Fe3O4-Au nanoparticles 
by high-temperature decomposition (> 450 OC) of iron pentacarbonyl on Au 
nanoparticles and oxidation in air.  These methods yielded heterodimers below 20 nm 
in diameter. Other preparation methods of metal oxide-Au composites led to the 
formation of composite particles over 100 nm in diameter.37, 38  
The well-known photocatalytic activity of TiO2 has led the semiconductor to 
be a material of intense study in the area of environmental treatment such as 
degradation of organic contaminants in wastewater and air.44  Deposition of Au (or 
Ag) on TiO2 nanostructures leads to increased photocatalytic activity and 
photoelectrochemical response due to the coupling between the noble metal and the 
semiconductor oxide.  The increased photoelectrochemical response results in 
reduced recombination of photogenerated charges.  Ag nanoparticles generated in a 
nanoporous TiO2 film under UV light exhibited reversible photochromatic behavior.45, 
46  The noble metal-TiO2 composite nanostructures have been generally prepared with 
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the following methods: (i) photoelectrochemical deposition of Ag or Au nanoparticle 
on TiO2 nanostructures,45-49 (ii) chemical reduction of precursor materials, HAuCl4 or 
AgNO3, on TiO2 nanoparticles.50    
 
2.3.2  Synthesis via aerosol methods 
Flame aerosol synthesis of oxide powders have typically been employed 
commercially in large-scale production of titania pigment and fumed silica additive.51, 
52  Flame processes have been effective in the synthesis of oxide-oxide composite 
particles9, 53-57 as well as single component oxide particles58-61.   
In the 1980s, Chung and Katz59 developed the counterflow diffusion flame 
burner to synthesize refractory oxides such as SiO2, Al2O3, and Fe2O3 in H2/O2 flame.  
Zachariah et al.58 investigated this counterflow geometry to see the effects of process 
variables such as precursor loading and flame temperatures on particle formation.  
Their results illustrated that flame temperatures were a key factor in particle 
morphology because of particle morphology dependence on chemical kinetic rates.  
In the late 1990s, Pratsinis and collaborators60 examined the effect of silicon 
precursors, organosilane compounds vs. SiCl4, on specific surface areas of the 
generated SiO2 particles in a diffusion flame reactor.  A smaller specific surface area 
of organosilane-derived SiO2 was attributed to the increase of the flame temperature 
involved with the additional combustion source from the organosilane precursors.  
Recently, Pratsinis and collaborators61 employed a premixed methane-oxygen flame 
to synthesize TiO2 nanoparticles from titanium tetraisopropoxide precursor and 
investigated various particle formation pathways by monitoring sampled particle 
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morphologies and flame temperatures.  Surface reaction was found to contribute to 
early particle growth in their reaction conditions.   
Mixed oxide powders are useful in industry in the area of ceramics, optical 
fibers, catalysts, and paint opacifiers.54  In early 1990s, Katz and collaborators 
demonstrated the flame synthesis of various metal oxide powders such as TiO2/SiO2, 
SiO2/GeO2, Al2O3/TiO2, V2O5/TiO2, and V2O5/Al2O3.53-55  Recently, Zachariah and 
collaborators62, 63 demonstrated aerosol-based sol-gel synthesis of nanoporous iron 
oxide and silica particles.  They also presented a method to coat an iron oxide layer 
on a strong oxidizer nanoparticle (potassium permanganate; ~150 nm).64  Serna and 
collaborators65 exhibited the direct synthesis of silica-coated γ-Fe2O3 hollow spherical 
particles (150 ± 100 nm) via the aerosol pyrolysis of precursors, iron ammonium 
citrate and TEOS dissolved in methanol.   
SiO2/TiO2 mixed nanoparticles have drawn a high level of interest because of 
an enhanced reactivity coming from a combined effect of photocatalytic activity of 
TiO2 and high absorption capability of SiO2.66  Since the early 1990s-report of the 
counterflow diffusion flame-synthesis of TiO2/SiO2 composites by Hung and Katz,54 
active studies on the aerosol-mediated formation of the mixed oxides and their 
catalytic activities have been reported.9, 56, 57, 66-71  For example, Ehrman et al.9, 56 
demonstrated the synthesis of SiO2/TiO2 and SiO2/Fe2O3 mixed nanoparticles 
(diameter < 100 nm) in an aerosol flame reactor.  High-temperature aerosol reactions 
(> 2300 K) led to a single-step generation of large amounts of the mixed 
nanoparticles.  They employed various mole ratio of the precursors, C6H18OSi2 versus 
TiCl4 or Fe(CO)5, to produce the phase-segregated nanoparticles with different 
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morphologies (Figure 2.2).  X-ray diffraction results along with transmission electron 
micrographs, electron energy loss spectra, and Fourier transform spectra illustrated 
the mole ratio-dependent distribution of the species.   
Theoretical studies have gained attention because of interest in achieving 
control of flame reactors.  Particle morphology of materials made by flame aerosol 
synthesis is a strong function of temperature and residence time.  Modeling and 
simulation studies61, 72-76 have been published relating particle morphology to 
measured process control parameters such as flame temperature, cooling rate, and 
precursor concentration.  A number of monitoring methods have been used including 
laser scattering,77 dynamic light scattering and thermophoretic sampling,54 particle 
mass spectrometry,78 Fourier transform infrared spectroscopy,9 and computer imaging 
analysis of transmission electron micrographs.79 
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Figure 2.2  Mole ratio-dependent morphologies of flame-synthesized SiO2/metal 
oxide mixed nanoparticles:  (a) SiO2/TiO2, (b) SiO2/Fe2O3.  The dark portions 
represent (a) TiO2 and (b) Fe2O3 respectively.9   
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2.4  Surface modification of metal oxide nanoparticles 
In addition to their intrinsic properties such as optical, electrical, and magnetic 
characteristics, surface modification of metal oxide nanoparticles is a key step to 
extend their applications in biological and medical areas.  Several ligands have shown 
their availability for surface modification of the metal oxide nanoparticles.  The 
ligands and the metal oxide surfaces reacting with the ligands are summarized in 
Table 2.1.  Details of the reactions of the metal oxide surface-modifying ligands are 
described as follows.  
2.4.1  Silanes 
Alkylalkoxysilanes with a functional group such as 3-aminopropyltriethoxy 
silane (APTES) and 3-aminopropyltrimethoxy silane (APTMS) are useful molecules 
to render functionalities on a metal oxide surface by the reaction with the surface 
hydroxyl groups.80  Reaction of silane compounds with a silica surface is a well-
established chemistry.81-85  Levy et al.86 modified the surface of silica-coated Fe2O3 
nanoparticles with anhydride-treated APTES to attach cancer-targeting hormones on 
the nanocomposites.  Martin and collaborators32 demonstrated differential 
functionalization to the inner versus outer surfaces of their silica nanotubes by 
sequential reaction with two different silanes in the process of the nanotube synthesis.  
Lee and collaborators87 applied a similar approach to iron oxide-layered silica 
nanotubes to have differentially-modified inner and outer surfaces with APTES and 
poly(ethylene glycol)-silane respectively.  APTES-modified interiors of the 
composite nanotubes were activated with glutaraldehyde to immobilize human IgG.   
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Table 2.1 Ligands and the ligand-functionalizing surfaces.88 
Ligand Name Reacting surfaces References 
R-SH 
R-S-S-R’ 
thiols 
disulfides 
Au, Ag, Cu, Hg, Fe 3-5, 112-115 
R C OH
O
 carboxylic acids 
metal oxides 25, 26, 33, 35, 
97, 98 
P
OH
OHR
O  
phosphonates 
phosphonic acids 
metal oxides 6-8, 49, 99-102 
R Si
O
O
O
R'
R'
R'  
siloxanes metal oxides 
32, 43, 80-87, 
89-96 
C
R
C
HO
R'
OH 
enediols transition metal oxides 
(TiO2, Fe2O3, ZrO) 
3, 34, 103-109 
HO CH2
C
R'
CH2
R
HO  
diols Fe2O3 
110, 111 
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 Silane chemistry has been employed extensively to modify the surface of iron 
oxide nanoparticles, maghemite (Fe2O3) and magnetite (Fe3O4).  Zhang and 
collaborators89, 90 adopted silane chemistry to magnetite nanoparticles in the 
application of the superparamagnetic nanoparticles for MRI (Figure 2.3).  They 
adapted APTES with a poly(ethylene) glycol (PEG)-bridge and terminal target-
recognizing functionalities such as folic acid and chlorotoxin to achieve the goals of 
improved particle suspension time in blood and adherence to the target cells at the 
same time.  They also achieved addition of dye molecules, Cy5.5, on the surface of 
the amine-functionalized magnetite surface for intraoperative optical application.  
Recently, Lin and collaborators91 demonstrated the usage of APTES-modified Fe3O4 
nanoparticles as controllable caps of mesoporous silica nanorods in their study of a 
controlled-release delivery system.  APTES-Fe3O4 nanoparticles capped the 
mesopores of the fluorescein-loaded nanorods through the reaction with 3-
(propyldisulfanyl)propionic acid functional groups on the pores.  The disulfide 
linkage was cleaved by cell-produced antioxidants and disulfide reducing agents to 
remove Fe3O4 caps from the mesopores and release florescein from inside of the 
mesoporous nanorods.  O’Connor and collaborators43 took advantage of affinity 
between Au and amine functional groups to attach Au nanoparticles around APTES-
modified Fe3O4 nanoparticles.  Hubbuch and Thomas92 illustrated the application of 
APTES-modified iron oxide nanocrystals in separation of trypsin from a mixture via a 
sequential modification of the APTES-iron oxide particles with polyglutaraldehyde, 
epicholorohydrin, and p-aminobenzamidine.  
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Figure 2.3  Schematic diagram of surface modification of Fe3O4 nanoparticles for 
MRI89, 90. (i) Activation of amine terminal group with N-succinimidyl iodoacetate, (ii) 
attachment of sulfhydryl-functionalized chlorotoxin to iodoacetate-modified particles. 
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Figure 2.4  Schemes of silane chemistry on iron oxide nanoparticles: (a) metal ion 
removal using imidazole functional groups grafted on γ-Fe2O3 nanoparticles,93 (b) 
bovine serum albumin (BSA) immobilization on Fe3O4 nanoparticles.94  
 
Xu and collaborators95 demonstrated APTES-modification of γ-Fe2O3 
nanoparticles in aqueous solution as well as in organic solutions such as toluene.  
They demonstrated the removal of divalent metal ions from solution with polymer-
grafted iron oxide nanoparticles (Figure 2.4(a)).93  For this purpose, they modified the 
terminal thiol group of 3-mercaptopropyltrimethoxysilane with poly(1-
vinylimidazole) and grafted the polymer on γ-Fe2O3 nanoparticles using silane 
chemistry.  Muhammed and collaborators96 modified APTMS-iron oxide particles 
with PEG to improve the biocompatibility of the magnetic particles.  They also 
demonstrated bovine serum albumin (BSA)-immobilization on iron oxide 
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nanoparticles in the succinimide-activated BSA treatment of the APTMS-iron oxide 
nanoparticles (Figure 2.4(b)).94  The BSA-immobilized magnetic nanoparticles did 
not cause cell damage and no endocytosis was seen in the incubation of the modified 
particles with human dermal fibroblast cells for 6 and 24 hours.  
2.4.2  Carboxylic acids 
Several reports are available describing the use of carboxylic functional 
groups in surface modification of iron oxide and titania nanoparticles.  Dyal et al.97 
demonstrated that enzymes immobilized on γ-Fe2O3 nanoparticles maintained their 
native activity for an extended period of one month.  They attached 11-
bromoundecanoic acid via the carboxylic linkage to the γ-Fe2O3 nanoparticles. After 
additional surface modifications, they then immobilized the enzyme via a C=N bond.  
Cheon and collaborators25, 26 illustrated recently that 2,3-dimercaptosuccinic acid 
(DMSA) was effective in surface modification of Fe3O4 nanocrystals through 
carboxylate bonding on the nanocrystals and intermolecular disulfide cross-linkages.  
They demonstrated size-dependent magnetic resonance (MR) signal intensity of the 
DMSA-modified Fe3O4 nanocrystals.  The spin-spin relation time-weighted MR 
signal intensity decreased as the size of the surface-modified magnetic nanocrystals 
increased from 4 to 6, 9 and 12 nm.  They achieved immobilization of cancer-specific 
antibodies on the magnetic nanocrystals by using the remaining free thiol groups of 
the surface-bound DMSA ligands.  They applied the antibody-immobilized magnetic 
nanocrystals to in vitro and in vivo mouse MRI.   
Dimitrijevic and collabotors35, 98 exhibited attachment of carboxyethyl β-
cyclodextrin on TiO2 nanoparticles via carboxyl linkages to the surface Ti atoms.  
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Surface-conjugated cyclodextrins were used as host molecules as the hydrophobic 
cavity of cyclodextrin is well-suited for host-guest interactions in aqueous solutions.  
They observed guest-oxidation potential controlling charge separation and trapping.  
The high oxidation potential of adamantane serving as a guest molecule prevented 
charge transfer between TiO2 and the entrapped guest, while the low oxidation 
potential of ferrocenemethanol led to oxidation and dissociation of the guest from the 
inclusion complex.  Weng and collaborators33 described size-controllable binding 
nature of all-trans-retinoic acid with TiO2 nanoparticles.  Their transient absorbance 
difference spectra demonstrated that chemical bonding became more dominant versus 
physisorption as the semiconductor nanoparticle-size decreased from 6 to 0.8-1.4, and 
0.7 nm.   
2.4.3 Phosphorous compounds 
 Organophosphorous compounds have attracted interest as an alternative to 
organosilane compounds in functionalization of inorganic surfaces due to their 
characteristic features such as a large number of available organophosphorous 
functional molecules and difference in surface reaction mechanisms between 
phosphorous- and silane-compounds.99  Many metal oxides, including metal oxides of 
titanium, aluminum, iron, steel, copper, and brass, have been used as matrix in 
organophosphorous compound-involved surface modification.99  Binding mode of 
organophosphorous molecules can be mono-, bi-, and tridentate as a combination of 
the property of functionalizing surfaces and the nature of the organophosphorous 
compounds.  Surface modification of TiO2 with phosphonates or phosphonic acids is 
an attractive topic because of the altered catalytic function of the transition metal 
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oxide surface.6  Phosphonates and phosphonic acids form self-assembled monolayers 
(SAMs) on TiO2 surface by the formation of Ti-O-P bonds.  Textor, Spencer, and 
collaborators have extensively studied alkyl phosphate-SAM formation on TiO2 in 
alkyl phosphate ammonium salt-dissolved aqueous solutions.7, 8, 100, 101  X-ray 
photoelectron spectroscopy was employed to study the binding of TiO2-alkyl 
phosphates.  Water contact angles on a SAM-formed surface depended on the nature 
of the tail group of the phosphates, either hydrophobic alkyl- or hydrophilic hydroxy-
alkyl groups.100  Grätzel and collaborators demonstrated dye-sensitized solar cells 
using a combined effect of photosensitivity of the TiO2 surface and surface 
modification-provided stability of the photovoltaic cells.102  An amphiphilic 
ruthenium compound and dodecyl phosphonic acids were bound to TiO2 surface to 
improve the lifetime of the solar cells.  Chen and Chen49 applied the affinity of TiO2-
phosphous compound to magnetic-field assisted separation of phosphopeptides from 
an enzyme-digest mixture using TiO2-coated Fe3O4 nanoparticles.       
2.4.4  Diols 
Bidentate binding of enediol ligands stabilizes undercoordinated surface metal 
atoms on the surface of transition metal oxide nanoparticles: TiO2, Fe2O3, and ZrO3.34  
This bidentate binding was reported to be characteristic of nanocrystalline metal 
oxide particles below 20 nm in diameter.  Enediol ligand-binding onto 4.5 nm TiO2 
nanoparticles altered the optical characteristics of the nanoparticles due to the shift in 
the dipole moment of Ti-ligand complexes.  Dopamine (DA) is of particular interest 
among the enediol ligands, since the terminal amine group of dopamine can be further 
modified by reaction with other functional molecules.  Dopamine pretreated with 
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functional molecules such as nitrilotriacetic acid (NTA) or biotin demonstrated a 
robust binding on iron oxide nanoparticles below 10 nm used for separation of 
histidine-tagged proteins or streptavidin.3, 103  DNA oligonucleotides were hybridized 
onto 4.5 nm TiO2 particles through dopamine-bridging and the photocatalytic, 
electronic, and bioactive characteristics of the TiO2-oligonucleotide nanocomposites 
were assessed. 104, 105  Size-dependent binding of enediol ligands such as dopamine on 
TiO2 nanocrystalline surfaces was the basis for tip-to-tip assembly of TiO2 
nanorods.106, 107  Biotinylated dopamine exhibited a preferential binding on 
undercoordinated Ti atoms at the highly-curved tips of the nanorods.  Reaction of 
avidin with the TiO2/DA-biotin structure resulted in a linear assembly of the nanorods.  
The presence of 3,4-dihydroxyphenylalanine (DOPA), the precursor of dopamine, is 
correlated with the adhesive properties of mussel adhesive proteins.  PEG-DOPA-
TiO2 nanoparticle complexes exhibited resistance to serum protein adsorption.108, 109 
Rotello and collaborators110 illustrated that 1,3-diols with bulky tail groups 
were attached to as-synthesized alkylamine-coated γ-Fe2O3 nanoparticles in an 
exchange reaction with the surface alkylamines.  They attributed the stability of the 
diol-modified magnetic nanoparticles to both the bidentate coordination of diols and 
steric stabilization of the bulky tail groups.  They demonstrated dendrimer-mediated 
self-assembly of the magnetic nanoparticles through an electrostatic interaction 
between cationic functional derivatives at the end of the 1,3-diol bulky tails and 
anionic polyamidoamine dendrimers.111  
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2.5  Multifunctional metal oxide nanoparticles and nanocomposites 
Multifunctionality of nanostructures including biobarrier-overcoming ability, 
target-specificity, and drug-delivery is a key feature to their biological applications.  
Differential functionalization of multi-component nanocomposites leads to 
fabrication of multifunctional nanostructures.  Differential functionalization of metal-
metal, metal-metal oxide, and metal oxide-metal oxide surfaces has been achieved via 
preferential binding of a given functional compound to a specific component and is 
described below.  
 
Differential functionalization of metal-metal surfaces:  Differential 
functionalization of metal-metal surfaces is achieved using multi-component 
nanowires synthesized in template-based fabrication methods.  Most of these 
approaches employ Au-metal nanowires to use thiol-affinity toward Au surface.  
Leong and collaborators5 demonstrated segment-dependent binding of DNA plasmids 
and targeting molecules to Au-Ni bimetallic nanowires.  They applied this approach 
to in vivo and in vitro gene delivery.  Mirkin and collaborators4 displayed  a 
magnetic-field assisted separation of histidine-tagged proteins by differential 
modification of Au-Ni-Au tri-segment nanowires with binding of thiolated PEG 
(PEG-SH) to Au end portions and affinity of histidine-groups to the Ni portion.  PEG-
SH binding to gold end segments functioned to suppress nonspecific binding of 
proteins and to stabilize suspension of the nanowires.  Metal-metal nanowires such as 
Au-Ni5 and Au-Pt4 exhibited the selective adsorption of functional molecules and 
proved their applicability in gene delivery and separation of histidine-tagged proteins.  
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Recent efforts to fabricate metal oxide-metal nanocomposites are described in Section 
2.3.1.   
 
Differential functionalization of metal-metal oxide surfaces:  Differential 
functionalization on metal oxide-Au heterodimeric nanoparticles was achieved using 
the preferential binding of a thiol group on Au surface over metal oxide surfaces.3  
Whiteside and collaborators demonstrated simultaneous differential functionalization 
of Au-alumina surface via preferential binding of Au-alkane thiol and alumina-alkane 
carboxylic acid.112  Since then a large number of applications have been reported 
using a similar approach to differently fabricated Au-metal oxide surfaces.113-115  
Specific binding interaction of Au-thiol compounds is also used for a differential 
modification of Au-metal oxide nanoparticles to acquire multifunctionality.  Very 
recently, Xu and collaborators3 developed binary nanoparticles of Fe3O4-Au via self-
assembly of metal oxide nanoparticles at liquid-liquid interface and partial exposure 
of the inorganic particle surface to a reactant, silver nitrate.  They employed a 
sequential surface-specific binding approach of Au-thiolated porphyrin and Fe3O4-
biotinylated dopamine. In this way, the differentially-modified Fe3O4-Au binary 
nanoparticles exhibited a dual function of porphyrin-related fluorescence and biotin-
mediated separation of avidin-functionalized molecules.     
 
Selective modification of metal oxide-metal oxide surfaces:  Selective reaction of 
functional molecules on a metal oxide-metal oxide surface is a challenging task 
compared with multifunctional reactions on metal-metal and metal-metal oxide 
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surfaces, since most functional groups exhibit a similar binding affinity to both the 
metal oxide surfaces.  Nonetheless, a few reports of selective functionalization on 
SiO2-TiO2 surfaces are available, using the preferential binding of phosphonic acids 
and organic phosphates on the TiO2 portions of the mixed metal oxide surfaces.  
Mutin et al.6 demonstrated through their solid-state NMR studies that phosphonic 
acids were bound on a SiO2 surface in toluene, an organic aprotic solvent (Figure 
2.5(a)).  However, the phosphonic acid-binding on the silica surface was not detected 
in an aqueous solution likely due to the hydrolysis of the Si-O-P bonds.  Much higher 
stability of Ti-O-P bonds against hydrolysis led to the formation of the bonds on a 
TiO2 surface via the reaction with the phosphonic acids in the aqueous environment.  
Both chemical bond formation and physical coordination of surface Ti atoms 
contributed to the binding of the phosphonic acids on the TiO2 surface.  In addition, 
scanning auger electron spectroscopy analysis of phosphonic acid-modified SiO2-
TiO2 support substantiated their NMR study results by showing a preferential binding 
of the phosphonic acid to the TiO2 region.  Based on their results, they suggested 
selective sequential functionalization of the SiO2-TiO2 mixed oxide surface by the 
following two steps: (i) preferential reaction of phosphonic acid on the TiO2 region, 
(ii) subsequent binding of trimethylsilyl group on the remaining SiO2 portion using a 
mild silylating agent, N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA).  Michel et 
al.7, 8 reported selective surface fabrication of a SiO2-TiO2 surface by using the 
preferential self-assembly of organic phosphates on the TiO2 region in an aqueous 
solution (Figure 2.5(b)).  The remaining SiO2 surface after the phosphate treatment 
became protein binding-resistant through adsorption of poly(L-lysine)-g-
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poly(ethylene glycol) (PLL-g-PEG) on the SiO2 portion.  They adopted X-ray 
photoelectron spectroscopy (XPS) and time-of-flight secondary ion mass 
spectrometry (ToF-SIMS) to characterize the selective modification of the mixed 
oxide surface.  XPS results for the carbon (1s) region along with ToF-SIMS mapping 
results demonstrated that organic phosphates were selectively bound on the TiO2 
surface and the subsequent PLL-g-PEG treatment led to adsorption of PLL-g-PEG on 
both TiO2/phosphates and SiO2 surfaces.  Immersion of the selectively-modified 
TiO2-SiO2 surface in full serum resulted in replacement of the loosely-bound PLL-g-
PEG on TiO2/phosphates with proteins while the SiO2/PLL-g-PEG surface was 
unaffected.  They proved through florescence microscopy and atomic force 
microscopy studies that chemical patterns could be constructed on the selectively-
modified TiO2-SiO2 surface with organic phosphates and PLL-g-PEG due to the 
protein-binding resistant character of the SiO2/PLL-g-PEG surface.   
  31 
 
 
P
O OO
Si
O
Si
O
P
O OO
P
O OO
P
O OO
DPA or DDP BSTFA
SiO2 TiO2
P
O OO
P
O OO
Proteins
Proteins
PLL-g-PEG
(a)
(b)
- - - - -
P
O OO
P
O OO
- - - - -  
 
Figure 2.5  Differential functionalizations of SiO2/TiO2 surfaces: Sequential 
functionalization with (a) DPA and BSTFA,6 and (b) DDA and PLL-g-PEG.7, 8  DPA: 
Dodecyl phosphonic acid, DDP: Dodecyl phosphate. 
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2.6  Cellular membranes and X-ray scattering 
2.6.1  E.coli cellular membrane 
Escherichia coli was used in Chapters 5 and 6 to demonstrate its magnetic 
field-assisted interactions with magnetic nanoparticles, SiO2/γ-Fe2O3 mixed particles.  
E. coli is gram-negative bacteria and the dimension of the E. coli cell is about 2 µm in 
length and a little less than 1 µm in diameter.  The cell envelope of gram-negative 
bacteria is composed of three layers: outer membrane, peptidoglycan layer and inner 
(cytoplasmic) membrane.116  Figure 2.6 demonstrates an electron micrograph of a 
gram negative cell wall. 
 
 
 
 
 
Figure 2.6  Electron micrograph of a gram negative cell wall.117  
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The peptidoglycan layer is generally 2-3 nm thick with the composition of 
cross-linked sugar polymers. The peptidoglycan layer helps the bacteria to maintain 
the shape and rigidity.  The cellular membranes are 7 nm in average thickness with 
the main composition of lipids and proteins. A fluid mosaic model of a cellular 
membrane (Figure 2.7) is generally used to understand the cellular membrane.    
 
2.6.2  X-ray scattering 
In this dissertation, the E. coli cell membrane-magnetic nanoparticle 
interactions were detected with X-ray scattering, as described in Chapters 5 and 6. X-
rays are electromagnetic radiation of wavelength in the range between 10 and 0.1 nm.  
A typical process of the generation of X-rays for X-ray scattering experiments is 
described as follows.  Monochromatic X-rays are produced when a beam of 
accelerated electrons in a high voltage such as 30 kV collide with a metal target, often 
copper.  Collisions with enough energy knock out some of the copper 1s (K shell) 
electrons.  Energy release in the transition of electrons from the outer-orbital (2p or 
3p) to the vacancy is emitted as X-ray radiation.  Copper 2p Æ 1s transition is called 
Kα with a wavelength of 1.5418 Å.  This Kα radiation is commonly employed in X-
ray scattering experiments.  
Bragg’s Law is used to measure the perpendicular distance between adjacent 
planes of crystals, the d-spacing, from X-ray scattering data.  The derivation of 
Bragg’s Law is presented in Appendix C.4.1.  
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Figure 2.7  Fluid mosaic model of a cell membrane. (a) A two dimensional model,118  
(b) an one dimensional model.119 
~70 Å
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Chapter 3: Magnetic iron oxide nanoparticles for bio-
recognition: Evaluation of surface coverage and activity 
 
3.1 Abstract 
Modifying the surface of magnetic nanoparticles (MNPs) by the covalent 
attachment of biomolecules will enable their implementation as contrast agents for 
magnetic resonance imaging or as media for magnetically assisted bioseparations.  
This chapter describes both the surface coverage and activity of IgG antibodies on 
MNPs.  The antibodies were immobilized on γ-Fe2O3 nanoparticles by conventional 
methods using aminopropyltriethoxy silane and subsequent activation by glutaraldehyde.  
Novel fluorescence methods were used to provide a quantitative evaluation of this well-
known approach. The results show that surface coverage can be stoichiometrically 
adjusted with saturated surface coverage occurring at ~ 36% of the theoretical limit.  
The saturated surface coverage corresponds to 34 antibody molecules bound to an 
average-sized MNP (32 nm diameter).  The results also show that the immobilized 
antibodies retain ~50% of their binding capacity at surface-saturated levels. 
 
3.2 Introduction 
Magnetic iron oxide nanoparticles (MNPs) are inherently biocompatible97, 120  
and are amenable to post-synthesis surface modification making them excellent 
candidates for many important applications. For instance, biotechnological 
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applications of MNPs include magnetic resonance (MR) imaging contrast agents,25, 26, 
89, 90 targetable drug carriers,11 hyperthermia-inducing agents121, 122 and magnetically 
controlled media for sensitive separation and detection of biomolecules.123, 124  In 
order to optimize MNPs for these applications it is necessary to confer a high level of 
binding-specificity through surface chemistry.  High specificity can be introduced by 
using biological moieties that possess lock-and-key interactions including those 
observed in antibody-antigen and enzyme-substrate recognition.  In surface 
modifications involving biomolecules, surface coverage is critically important as is 
the ability for the immobilized molecules to retain their native conformations and 
binding profiles. 
One extremely useful route to post-synthetic modification of iron oxide 
nanoparticles is accessed by employing the common organosilane reagent, γ-
aminopropyl triethoxy silane (APTES).95 This approach has been used to produce 
polymer grafted magnetic nanoparticles (MNPs)89, 93, 96 and to attach proteins to iron 
oxide nanoparticles.94, 125  Studies of bovine serum albumin immobilized in this way 
on MNPs showed that the coated nanoparticles remain superparamagnetic and that 
they undergo translocation into human dermal fibroblast cells.94 Attachment of the 
enzyme horseradish peroxidase (HRP) to APTES-modified iron oxide nanoparticles 
was demonstrated by Ma et al125 and the immobilized HRP remained enzymatically 
active with a surface coverage approximately two times greater than with native 
particles.  These previous studies have relied upon thermogravimetric and chemical 
analysis to evaluate surface modification of nanoparticles prepared at a single protein-
nanoparticle stoichiometry.  Here this approach is complemented and expanded by 
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using fluorescence spectroscopy to report a full chemisorption isotherm analysis. 
Fluorescence microscopy is also employed to confirm antibody activity. 
This chapter reports the characterization of surface coverage, as well as 
antibody activity, of amine-coated MNPs modified with anti-mouse immunoglobulin 
G (IgG) antibodies (Scheme 3.1).  The results gained from these studies are of 
obvious importance since the antibody/antigen interaction can be exploited for a 
variety of target molecules and organisms.  APTES provides a common intermediate 
that is amenable to a wide range of subsequent modifications, particularly with 
respect to biomolecule immobilization.  In principle, any soluble protein can be 
immobilized using glutaraldehyde as a cross linker between an amine functional 
group on the protein and the APTES surface groups.  However, proteins with amine 
side chains (i.e. lysine residues) may have multiple points of attachment which 
introduce a further level of complexity in terms of the possible orientations.126, 127  To 
investigate the applicability of the APTES approach for antibody immobilization on 
MNPs, the well-characterized anti-IgG antibody has been immobilized.  
Fluorescence-based assays have provided a quantitative determination of surface 
coverage and evaluated the activity of the attached antibody.  Fluorescence assays 
provide high sensitivity and avoid problems due to spectral overlap between the iron 
oxide nanoparticles and fluorophores when both are present since iron oxide is not 
fluorescent.  These methods provide valuable quantitative information and should be 
applicable to a wide range of ligands. 
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Fluorescein-labeled 
anti-mouse IgG 
APTES
Si
(CH2)3NH2
O OO
32 nm
OHC(CH2)3CHO
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(CH2)3N
O OO
CHO
Si
(CH2)3N
O OO
N
(a)
(b)
γ-Fe2O3  
nanoparticle 
Alexa Fluor 568-labeled 
mouse IgG 
Scheme 3.1 (a) Surface modification of γ-Fe2O3 nanoparticles with APTES for the 
immobilization of fluorescein-labeled anti-mouse IgG (FL-anti-mouse IgG). (b) 
Separation of Alexa Fluor 568-labeled mouse IgG (AF-mouse IgG) using the anti-
mouse IgG antibody coated MNPs. 
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3.3 Experimental methods 
3.3.1 Materials 
The γ-Fe2O3 particles were purchased from a commercial source (Alfa Aesar, 
Ward Hill, MA). The surface area of the particles is 42 m2/g (determined by BET 
measurement) and the average size is 32 ± 18 nm (from TEM).  These values are 
consistent with published values95, 128 and those supplied by the manufacturer.  
Reagent grade 3-aminopropyltriethoxysilane (APTES) and glutaraldehyde were 
purchased from Sigma (St. Louis, MO) and polysciences (Warrington, PA), 
respectively. FL anti-mouse IgG and purified mouse IgG in phosphate buffered saline 
(PBS; pH 7.4, 0.05 % sodium azide), were purchased from Invitrogen (Carlsbad, CA) 
and from Zymed (South San Francisco, CA), respectively.  Alexa Fluor 568 
succinimidyl ester was purchased from Molecular Probes (Eugene,OR).  All 
chemicals were used as received without further purification except mouse IgG which 
was dialyzed to reduce the concentration of sodium azide prior to the dye-labeling 
reaction (see below). 
 
3.3.2 APTES modification of magnetic iron oxide nanoparticles 
All glassware was soaked in piranha solution (conc. H2SO4 and 35% H2O2, 
3:1 v/v) for one hour and rinsed with distilled water before use. 1.5 g of γ-Fe2O3 
nanoparticles was dispersed in 45 mL of distilled water using sonication to produce a 
homogenous suspension.  The suspension was then purged with nitrogen in a three-
necked flask.  5 mL of APTES was added to the suspension drop-wise for a final 
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concentration of 10 % APTES (v/v).  The solution was refluxed for 3 h at 120 °C 
under nitrogen atmosphere and with vigorous mechanical stirring.  The APTES-
modified particles were collected in a centrifuge tube using a neodymium-iron-boron 
permanent magnet (Arbor Scientific, Ann Arbor, MI) and then washed with double 
distilled water three times and with ethanol once.  The harvested particles were dried 
in vacuum overnight and stored in a desiccator.  
 
3.3.3 Preparation of antibody-coated iron oxide nanoparticles through crosslinking 
with glutaraldehyde 
Magnetic nanoparticles were coated with the fluorescently labeled secondary 
antibody, goat anti-mouse IgG.  10 mg of the APTES-modified nanoparticles were 
added in 0.5 mL of PBS (pH 7.4) and sonicated for 5 min. 1.5 mL of 8 % 
glutaraldehyde solution in PBS was added to the particle suspension and the mixture 
was vortexed briefly.  The suspended particles were mixed gently for 6 h at room 
temperature. The activated particles were magnetically collected and washed three 
times with PBS and then suspended in 4.0 mL of PBS.  80 µL of the suspension (0.20 
mg of particles) was added to a PBS solution of anti mouse IgG for a final volume of 
1.0 mL and shaken for 20 h at room temperature.  The resulting surface-modified 
MNPS were harvested and washed four times with 1 mL of PBS. The supernatant and 
washing solutions were kept to determine the amount of unreacted antibody. 
Quantitative determination of the amount of unreacted antibody was used to 
calculate the degree of surface coverage.  This approach was necessary for accurate 
quantification of antibody binding since absorption and scattering artifacts along with 
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particle settlement during measurement prevent the direct accurate measurement of 
conjugation in the actual product.  The amount of unreacted dye was fluorometrically 
determined after first establishing a standard calibration curve (Appendix A).  The 
amount of dye-labeled antibody bound to the nanoparticles was calculated using the 
following equation: 
Amount of bound antibody  
= initial quantity of antibody – unreacted quantity of antibody 
Interestingly, it was found that upon binding of the dye-labeled antibody to 
the nanoparticle surface, the emission efficiency of the fluorescein label was 
decreased by ~200 fold.  Quenching of the immobilized fluorophore upon surface 
immobilization is further reason for measuring unreacted antibody to determine 
surface coverage. 
 
3.3.4 Dye-labeling of target antibody 
The dye labeling of mouse IgG was carried out using methods described by 
the dye supplier.  In brief, mouse IgG (2.5 mg/mL) in 10 mM PBS (pH 7.4, 0.05% 
sodium azide) was dialyzed using a Spectra/Por (Rancho Dominguez, CA) dialysis kit 
(molecular weight cut-off 50,000) to reduce sodium azide concentration.  Next, 0.2 
mL of 1 M sodium bicarbonate buffer (pH 8.5) was added to 2 mL of the dialyzed 
antibody solution to attain the appropriate pH for the attachment of dyes.  1 mg of 
Alexa Fluor 568 succinimidyl ester dissolved in 0.1 mL of DMSO was added to the 
antibody solution and mixed for 1 h.  Alexa Fluor 568 labeled-mouse IgG (AF-mouse 
IgG) was separated from the unreacted dye with gel permeation chromatography 
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using Sephadex G-25 (Amersham Biosciences, Piscataway, NJ).  The degree of 
labeling of the resulting protein-dye conjugate was determined by UV-Vis absorbance 
at 280 nm and 575 nm to be 0.20 mg/mL for an average of 4.4 attached dye 
molecules per antibody. 
 
3.3.5 Magnetic immobilization of target antibody (mouse IgG) using the anti-mouse 
IgG modified MNPs 
Antibody coated magnetic nanoparticles (400 µL of 10 mg MNP/20 mL) were 
added to 600 µL of AF-mouse IgG.  A range of AF-mouse IgG concentrations were 
studied.  Samples were mixed for 3 h, collected and washed four times each with 1 
mL of PBS.  Steady-state fluorescence was used to evaluate the amount of bound 
primary antibody.  Fluorescence spectra of the magnetically captured nanoparticle 
suspensions were taken with excitation wavelength of either 480 nm for excitation of 
fluorescein or 550 nm for excitation of Alexa Fluor 568. 
 
3.3.6 Fluorescence microscopy and spectroscopy 
Steady state fluorescence measurements to evaluate antibody surface coverage 
and reactivity were conducted with either a Spex Fluorolog-3 fluorometer (Horiba 
Jobin Yvon Inc, Kyoto, Japan) or a Hitachi F-4500 fluorescence spectrophotometer 
(Tokyo, Japan).  For the quantitative determination of the concentration of fluorescein 
in washings and supernatant solutions, a calibration curve was first established over 
the dye concentration range of interest.  The fluorescence intensity was linear with 
dye concentration over the entire calibration curve.  Care was taken to conduct the 
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experiments under the same conditions used to establish the calibration curve to avoid 
pH and instrument effects when determining the experimental dye concentration. 
Fluorescence images and spectroscopic data were acquired using a sample 
scanning confocal microscope.  The microscope was described previously129, 130 and 
consists of a modified Axiovert 200 (Carl Zeiss, Oberkochen, Germany) with a 
NanoBio-2 (Mad City Labs, Madison, Wisconsin) closed-loop, piezoelectric scanning 
stage for nanometer precision.  The microscope is equipped with a 15 cm 
monochromator with a 150 g/mm grating (Acton Research Corporation, Acton, MA) 
for acquisition of emission spectrum from any region of a confocal image with high 
spatial resolution (300 nm) and positioning accuracy (< 10 nm).  For confocal 
microscopy studies, the particles in PBS were spin coated on a glass slide and imaged 
with 488 nm laser light (Melles Griot, Carlsbad, CA).  
 
3.3.7 X-ray photoelectron spectroscopy 
XPS measurements were performed using an AXIS 165 spectrometer (Kratos 
Analytical Inc, Chestnut Ridge, NY) with monochromatic Al Kα x-ray source (144 
W). A sample of powder, loaded onto a conductive carbon tape on a stub, was put 
into the vacuum chamber under a background pressure of 4 × 10-10 Torr.  Wide scan 
surveys and specific regions (for example, C1s, N1s) were measured in hybrid mode 
using both electrostatic and magnetic lenses with a step size of 0.1 eV.  XPS spectra 
were recorded in the FAT analyzer mode with pass energy of 80 eV and an average of 
ten scans. The charge neutralizer was off during the measurements and calibration of 
binding energy was carried out with respect to C1s at 284.6 eV.  Data processing was 
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done using Vision processing software(Kratos Analytical Inc, Chestnut Ridge, NY).  
After subtraction of a linear background, all spectra (except Fe2p) are fitted with 60% 
Gaussian /40% Lorentzian peaks, taking the minimum number of peaks consistent 
with the best fit. 
 
3.3.7  Transmission Electron Microscopy (TEM) 
Nanoparticle size and size distribution for unreacted-, APTES-modified, and 
FL-anti IgG immobilized MNPs were characterized with TEM using a Zeiss 
EM10CA microscope.  For TEM sample preparation MNPs were suspended in PBS 
(pH 7.4) and then drop cast on a TEM grid.  TEM images are provided in Appendix 
A.15.  
 
3.4 Results and Discussion 
The initial MNP surface modification step, reaction with APTES, was verified 
using X-ray photoelectron spectroscopy (XPS).  The XPS results are summarized in 
Figure 3.1.  Each panel of Figure 3.1 displays a region of the XPS spectrum 
corresponding to binding energies of an element that is characteristic of APTES or 
iron oxide.  For comparison, the XPS spectrum of bare unmodified MNPs is 
represented by Trace a in each panel while Trace b corresponds to the MNPs after 
reaction with APTES.  
  Comparisons of the peaks in each panel clearly show the appearance of new 
features at the binding energies of carbon, nitrogen and silicon.  The C1s peaks at 
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284.8 eV and 287.7 eV in Traces a and b are from the carbon tape which is used to 
introduce the powder samples into the UHV chamber of the XPS.  The additional 
peak at 286.5 eV, appearing in the XPS spectrum of the modified nanoparticles 
(Trace b), is assigned to the terminal methylenes of the propyl group (i.e. CH2-N and 
CH2-Si).  The broad N1s peak appearing at 402 eV is from the amine functional 
group in both protonated and unprotonated form present in APTES.95  There was no 
change in binding energy or peak shape observed in the Fe2p region for the magnetic 
particles before and after the silanization reaction with APTES. 
   XPS measurements of the carbon tape used to mount the samples confirmed 
the presence of a Si2p peak at 101.5 eV.  This peak is evident in the spectrum from 
the bare nanoparticles and is attributed to silicon impurities in the carbon tape.  The 
Si2p peak broadens significantly after the nanoparticles are reacted with APTES and 
was fit using a pair of Gaussians as shown in Figure 3.1.  One Gaussian represents the 
peak present in the bare carbon tape spectrum and the second Gaussian, centered at 
103.9 eV, is assigned to the APTES silicon atom bound to the iron oxide surface.  
This peak position, while occurring at a higher energy than previously reported by 
Finch and coworkers for APTES on γ-Fe2O3,95 is consistent with values for Si2p in 
silicates131 and indicates that the surface bound APTES may be substantially cross 
linked.  The APTES-modified nanoparticles were magnetically isolated and 
extensively rinsed before preparing XPS samples; therefore, the presence of new 
carbon, silicon and nitrogen peaks in the XPS spectra must arise from covalently 
attached, and not simply physisorbed, APTES.   
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Figure 3.1 XPS spectra of γ-Fe2O3 nanoparticles: a) unmodified γ-Fe2O3 
nanoparticles, b) APTES-modified γ-Fe2O3 nanoparticles.  
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Freshly prepared APTES modified particles were next modified by reaction 
with glutaraldehyde to activate the amine group for protein conjugation.  Protein 
conjugation was carried out by reacting 1.0 mL aliquots containing a fixed 
concentration of glutaraldehyde-activated nanoparticles with different concentrations 
of fluorescently-labeled anti-IgG antibody.  Quantitative fluorescence assays were 
conducted to determine the degree of surface coverage as a function of antibody 
concentration (described in Experimental Section).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2  Adsorption isotherm of fluorescein-labeled anti-mouse IgG 
antibody on γ-Fe2O3 nanoparticles. ●: glutaraldehyde-activated amino γ-Fe2O3 
particles, ϒ: plain γ-Fe2O3 particles.      
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Figure 3.2 shows the chemisorption isotherm for FL anti-mouse IgG on 
glutaraldehyde-activated APTES-coated nanoparticles (solid circles) and on bare γ-
Fe2O3 nanoparticles (empty squares).  The bare nanoparticles were used as a control 
sample for determining the amount of nonspecific binding.  In both cases, the surface 
coverage increases linearly at low antibody concentrations and is followed by a 
plateau region beginning near 160 µg  of added anti-IgG per mg of APTES-modified 
MNPs and at 60 µg of added anti-IgG per mg of bare MNPs.  In the case of bare 
nanoparticles, it is assumed that the saturation concentration is determined by 
adsorption/desorption kinetics of the antibody and the curve can be well described as 
a Langmuir isotherm (dotted line).  For modified nanoparticles coated with activated 
APTES, formation of a Schiff base occurs between the free aldehyde group on the 
nanoparticle and amine groups on the antibody surface.  This provides a stable 
covalent attachment and hence there is no observable desorption of the antibody.126, 
127  This is shown by the isotherm in which the linear region at low concentrations 
increases in direct proportion with the antibody in solution until the binding sites are 
saturated as indicated by the plateau at 160 µg  of added anti-IgG. 
The plateau corresponds to the loading capacity of available binding sites on 
the glutaraldehyde activated particles and extrapolates to 122 µg anti-IgG per mg 
MNP.  Based upon known antibody molecular dimensions (Y-shape; height = 8.5 nm, 
width = 14.5 nm, thickness = 4.0 nm)132 the antibody footprint on the immobilizing 
surface can vary from 34 to 120 nm2 depending on binding orientation. If the 
antibody binds to the surface through the Fc domain the per-molecule “footprint” 
should be 58 nm2. The average surface area for the magnetic iron oxide nanoparticles 
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from BET measurements is 42 m2/g.  These values indicate that a close-packed 
monolayer of Fc-bound IgG antibody would correspond to 200 µg anti-IgG/mg MNP.  
Hence the observed saturation at 122 µg anti-IgG/mg MNP is 61% of the theoretical 
monolayer for this orientation.  For maximum theoretical surface loading the antibody 
must bind in an edge-on orientation with the minimum footprint of 34 nm2.  In this 
case the observed saturation value would correspond to 36% coverage for this optimal 
orientation.  The calculations assume homogeneous orientation, rectangular footprints 
and perfect packing of the bound antibodies.  In reality the antibodies will have mixed 
orientations126, 127 and a monolayer with surface coverage below the theoretical 
maximum of 330 µg anti-IgG/mg MNP (assuming a homogeneous edge-on 
orientation for all bound IgG) can be expected.  Therefore, it is likely that our 
saturation value represents the maximum level of surface coverage obtainable with 
mixed orientations. 
The fact that 36% of the theoretical maximum coverage is obtained indicates 
that the activated-APTES surface-modification is a good promoter of efficient 
coverage by the antibody.  In comparison, bare nanoparticles exhibit only nonspecific 
adsorption which saturates at 20 µg anti-IgG/mg of the bare nanoparticles and this 
value corresponds to 6% of the theoretical monolayer.  Therefore, a six-fold increase 
is observed in surface coverage for APTES-modified nanoparticles corresponding to 
34 antibody molecules for an average size nanoparticle with 32 nm diameter.   
        In addition to adequate surface coverage, retention of bioactivity is critical for 
producing modified MNPs capable of bio-recognition.  To investigate whether the 
immobilized antibody remains active on the nanoparticle surface, magnetic-based 
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separations were conducted.  In these experiments the immobilized antibody (anti-
mouse IgG) is used to capture and hold a target antibody (mouse IgG) that is present 
in solution.  The MNPs are then magnetically separated and the amount of captured 
target antibody is measured and plotted against target antibody solution concentration 
(Figure 3.3C).  The MNPs used in this study were coated with anti-mouse IgG at 
levels corresponding to the saturation point in Figure 3.2 to ensure that the particle 
surfaces are initially well coated with anti-mouse IgG.  The concentration of MNPs 
was the same in all separations.  The target antibody, mouse IgG, was labeled with 
Alexa Fluor 568 (AF) as described in the supporting information.  The dye-labeling 
was performed on both the immobilized and the target antibody to enable direct 
spectroscopic verification of binding, separation and co-localization.  In actual 
applications this is not necessary. 
          Magnetic separation was performed by manually positioning a permanent 
magnet for 10 seconds on the side of a 5 mL-capacity vial containing a mixture of 
MNPs and target antibody in order to concentrate the MNPs so that the supernatant 
could be removed by pipette.  The magnetically captured nanoparticles were rinsed 
and re-suspended in phosphate buffered saline (PBS, pH 7.4) after which 
fluorescence emission spectra were acquired to determine the amount of captured AF-
mouse IgG.  Figure 3.3A shows the emission spectra acquired from the magnetically 
captured nanoparticles after exposure to four different concentrations of AF-mouse 
IgG.  The dashed lines in Figure 3.3A and 3.3B represent spectra acquired from FL-
anti-mouse IgG nanoparticles in the absence of AF-mouse IgG and show no peak at 
603 nm as expected.   
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Figure 3.3  Fluorescence analysis of magnetic separations performed on mouse 
IgG.  MNPs were labeled with anti-mouse IgG and used to isolate mouse IgG.  
To verify the separation, anti-mouse IgG was labeled with fluorescein (λmax=520 
nm) and mouse IgG was labeled with Alexa Fluor 568 (λmax= 603 nm). Emission 
spectra of magnetically isolated MNPs were collected at two excitation 
wavelengths in panels A and B.  (A) Excitation at 480 nm directly excites the 
fluorescein of anti-mouse IgG.  (B) Excitation at 550 nm directly excites the 
Alexa Fluor label on mouse IgG.  The spectra in A and B were acquired from 
MNPs that were magnetically isolated from solutions of AF-mouse IgG ranging 
in concentrations from zero (dashed lined) to 500 µg IgG/mg MNP.  Arrows 
above the peaks in (A) and (B) indicate the direction of change with increasing 
concentration of Alexa Fluor-labeled mouse IgG.  (C) Amount of magnetically 
captured Alexa Fluor 568-labeled IgG as monitored by the areas under the 
fluorescence spectra of (B). 
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          In Figure 3.3A the excitation wavelength used was 480 nm for direct excitation 
of the FL-anti-mouse IgG.  The data show that, as the AF-mouse IgG concentration is 
increased, a decrease in emission from the immobilized FL-anti-mouse IgG is 
observed.  The decrease in FL emission is accompanied by increasing emission from 
the AF-mouse IgG.  The increasing intensity of the AF fluorescence is due to 
increased binding in proportion with the added antibody.  The quenching of the FL 
emission with increasing binding is likely due to Förster-type energy transfer in 
which FL acts as the fluorescence resonance energy transfer (FRET) donor and AF 
acts as the FRET acceptor.  The observed FRET efficiency133 is weak (approx. 15-
30%) but indicates that the dyes must be separated by an average distance of less than 
10 nm since the calculated Förster distance (dye separation-distance at which energy 
transfer is 50%) for the dye pair is 6.0 nm.  Hence, the presence of energy transfer 
provides strong evidence that the dyes are co-localized through antibody—antigen 
interactions. 
In Figure 3.3B, emission spectra were acquired from the magnetically isolated 
particles using direct excitation of the AF dye (λex= 550 nm).  Direct excitation of 
AF-mouse IgG provides better quantification of the amount of captured antibody, and 
data obtained in this way were used to construct the binding curve shown in Figure 
3.3C. The area under the AF peak (590-700 nm) in Figure 3.3B was determined after 
correction for background and is plotted against the IgG solution concentration in 
Figure 3.3C to form a binding isotherm.  Saturation was reached at 150 µg IgG/mg 
MNP, nearly the same point as the chemisorption isotherm (160 µg anti-IgG/mg 
MNP) obtained for the initial immobilization of anti-mouse IgG on the APTES 
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modified nanoparticles (Figure 3.2).  The closely corresponding saturation points of 
the two isotherms indicate that 1:1 binding is observed between the immobilized anti-
mouse IgG and target mouse IgG.  If the bound antibody is chemisorbed through a 
lysine in the Fc domain as suggested in Scheme 3.1, then both Fab regions are 
available for binding in which case 2:1 binding would be observed.  The actual case is 
presumably more complicated than depicted by Scheme 3.1 since the antibody 
molecules can react with the surface in a range of orientations due to the occurrence 
of multiple lysines as suggested by the original chemisorption isotherm in Figure 3.2.  
Therefore, if multiple orientations exist it may be assumed that some orientations will 
result in reduced binding, i.e. the ability to bind only one or even zero mouse IgG.  
The observed 1:1 binding is therefore interpreted as an average value obtained from a 
distribution of molecular orientations capable of binding zero, one or two IgG 
molecules and agrees with our proposed model of monolayer coverage composed of 
randomly oriented anti-mouse IgG.  An alternative explanation is that only 50% of 
the antibody remains active at the surface due to denaturation from surface 
interactions.  A combination of denaturation and packing effects could also be 
responsible for the diminished activity.  The relevant issue, however, is that APTES 
immobilized antibodies will retain an overall level of 50% activity without the need 
for extensive surface preparation or biochemical modification of the antibody.  Our 
observation of 50% activity agrees well with values obtained from immobilized 
antibodies on planar surfaces.127  It was noted that nanoparticle precipitation occurs 
over a period of minutes in the absence of stirring, and this was true for any of our 
nanoparticle products, regardless of surface chemistry.  No change in this behavior 
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was observed when AF-mouse IgG was captured, indicating that aggregation or 
solubility is not strongly affected by the changes in surface chemistry used here.  
Throughout our measurements care was taken to ensure that the samples were well 
dispersed during acquisition of spectra. 
To verify that the antibodies were indeed co-localized, samples were prepared 
for imaging with confocal microscopy and micro-spectroscopy.  In these experiments 
a drop of magnetically isolated particles were spin coated onto a glass coverslip.  Spin 
coated samples were prepared from magnetically isolated nanoparticles from 
solutions before and after adding mouse IgG.  Figure 3.4A shows a confocal 
fluorescence micrograph that was acquired from a sample corresponding to the 
middle of the saturated region in Figure 3.3C (350 µg of added IgG/mg MNP).  
Spatially-resolved fluorescence spectra were collected from individual points in the 
fluorescence image by positioning the focal point (370 nm FWHM) of the excitation 
laser at the desired image locations.  
Figure 3.4B shows two spectra that were obtained by averaging individual 
spectra from 10 different image locations of two different samples.  Spectra were 
averaged to provide an unbiased representation of the sample.  The spectrum acquired 
from nanoparticles in the absence of AF-mouse IgG (green line) shows only the 
characteristic FL band.  The spectrum acquired from nanoparticles that were isolated 
from mixtures containing AF-mouse IgG (red line), shows emission from both 
fluorophores indicating that the dye molecules are co-localized.  Further evidence for 
co-localization can be taken from the relative intensities of the two fluorophores.  
Each of the spectra in Figure 3.4B were acquired with an excitation wavelength of 
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488 nm and at this wavelength the molar extinction coefficient for FL is 
approximately 12 times greater than that of AF.  Therefore, the enhanced emission of 
AF relative to FL is noteworthy.  A probable explanation for this observation is that 
the fluorophores undergo energy transfer as suggested by the ensemble spectra of 
Figure 3.3.  The occurrence of energy transfer observed throughout the sample 
indicates that the two fluorophores are consistently co-localized within 10 nm of each 
other.  This could only occur through specific binding of the immobilized antibody 
with its target antibody.   
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Figure 3.4  Spectra of spin-coated MNPs excited with 488 nm Ar-ion laser.   a) 
Confocal micrograph of spatially segregated fluorescein anti-mouse IgG antibody-
immobilized MNPs after mixing with AF-mouse IgG. (b) Normalized emission 
intensity of fluorescein anti-mouse IgG antibody-immobilized MNPs before (green 
line; average of 15 spectra from different points of the micrograph) and after (red 
line; average of 12 spectra) mixing with AF-labeled mouse IgG.  
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3.5 Conclusion 
In this chapter, APTES provides a convenient route for protein immobilization 
on nanosize iron oxide particles by demonstration of the attachment of anti-IgG 
antibody on the MNPs.  A chemisorption isotherm was acquired using fluorescence-
based assays of dye-labeled antibodies. Minimum saturating surface coverage with 
anti-IgG antibody was determined to be 36%.  This corresponds to monolayer 
coverage by approximately 34 randomly oriented antibodies on an average diameter 
MNP of 32 nm.  Magnetically assisted extraction of the target antibody, mouse IgG, 
from solution was conducted and results show that the immobilized antibody retains 
the ability to bind a target antibody.  Surface modification of  MNPs with activated 
APTES should provide a convenient platform for sensitive detection and separation 
of biological entities such as cells,123, 134, 135 proteins,103, 136, 137 viruses,124 and DNA.120   
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Chapter 4: Differential functionalization of SiO2/TiO2 mixed 
nanoparticles: an X-ray photoelectron spectroscopy study 
 
4.1 Abstract 
In this chapter differential functionalization of aerosol phase-synthesized 
SiO2/TiO2 mixed nanoparticles is demonstrated via X-ray photoelectron spectroscopy 
(XPS) analysis.  The particles were functionalized using aqueous phase-mediated 
preferential binding of phenyl phosphonic acids (PPA) to TiO2 and subsequent 
binding of trimethyl silyl ((CH3)3Si-) groups to the remaining SiO2 surface.  The 
particles include pure SiO2 and TiO2, plus SiO2/TiO2 composite nanoparticles with 
three different mole ratios of Si:Ti = 5:1, 1:1, and 1:5.  The analysis of surface 
chemical components measured via XPS is used to confirm differential 
functionalization of SiO2/TiO2 composite nanoparticles.  After aqueous-phase 
reaction with PPA, SiO2/TiO2 mixed nanoparticles and TiO2 nanoparticles 
demonstrate 0.05 bound phosphorous molecules per surface Ti molecule, whereas no 
phosphorous peak is detected on PPA-reacted SiO2 nanoparticles.  80% ± 10% of the 
P to Ti ratio is retained after reaction of the PPA-reacted mixed nanoparticles with 
BSTFA.  XPS spectra in C 1s and Ti 2p region indicate the trimethyl silyl group 
binds to the nanoparticles in the silanation step.  PPA bound in tridentate mode may 
be found not only on the bulk TiO2 surface but also at the SiO2-TiO2 interface.    
 
  58 
 
4.2 Introduction 
Differential functionalization of metal-metal,4, 5, 39, 88, 138-142 metal-metal 
oxide,3, 12, 37, 38, 112-115 and metal oxide-metal oxide6-9, 99 surfaces is useful in biological 
applications such as the construction of selective molecular assembly patterns7, 8, 114 
and the fabrication of multifunctional nanostructures3-5, 88, 138.  Selective binding of a 
functional compound to a specific portion of a multi-component surface is crucial to 
obtain differentially-functionalized heterogeneous surfaces.   
Thiol compounds (R-SH) are a typical example of functional molecules which 
show selectivity in noble metal-metal and noble metal-metal oxide systems due to 
their specific affinity for noble metals including Au and Ag.  In their early pioneering 
work, Whitesides and collaborators112 demonstrated simultaneous differential 
functionalization of Au-alumina surface using Au-alkane thiol and alumina-alkane 
carboxylic acid interaction.  Since then, the formation of a self-assembled monolayer 
of thiols on noble metals has frequently been employed to differentially modify 
metal-metal4, 88, 141 and metal-metal oxide surfaces3, 112-115.   
Finding a functionality that can bind selectively to one portion of a metal 
oxide-metal oxide surface is a highly challenging task, since most functional 
molecules show a similar binding affinity to different metal oxide surfaces.  For 
example, organosilanes, widely-used inorganic surface-functionalizing compounds, 
exhibit binding to both areas of SiO2-metal oxide surfaces.6  Recent studies show that 
organophosphorous compounds are a promising candidate for selective 
functionalization of SiO2-metal oxide surfaces101.  Textor and collaborators7, 8 
demonstrated the selective self-assembly of alkane phosphates on the TiO2 portion of 
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lithographically fabricated TiO2-SiO2 surfaces.  Subsequent adsorption of poly(L-
lysine)-g-poly(ethylene glycol) (PLL-g-PEG) to the remaining SiO2 area led to a 
patterned surface.  Proteins were selectively bound to the TiO2 surface, not to the 
protein-binding resistant SiO2 portion by the adsorbed PEG-compounds.  Mutin et 
al.6, 99 illustrated a selective phosphonic acid-binding to the TiO2 surface of SiO2-
TiO2 supports.  31P solid state nuclear magnetic resonance (NMR) spectra along with 
scanning Auger electron spectra were consistent, confirming the selective binding 
between TiO2 and phosphonic acid.  Further treatment of phosphonic acid-bound 
SiO2-TiO2 supports with a trimethylsilyl compound, N,O-
bis(trimethylsilyl)trifluoroacetamide (BSTFA), led to formation of Me3Si-O-Si bonds 
on the SiO2 surface according to 29Si solid state NMR spectra.               
Multifunctional nanoparticles are desired in many biological applications such 
as nanoparticle-based cancer treatments11 requiring drug-loading, biobarrier-
overcoming, target-recognizing capability and extended stability in the blood stream.  
Solution-phase synthesized composite nanostructures, such as multi-component 
metal-metal nanorods,4, 5, 88, 141-143 and combined nanoparticles of metal-metal39 and 
metal-metal oxide3, 12, have been differentially functionalized for biological 
applications as multifunctional nanoparticles.  Research in this Chapter is aimed at 
differential functionalization of aerosol-phase synthesized SiO2/TiO2 mixed 
nanoparticles via selective binding of phosphonic acids to TiO2 and subsequent 
trimethylsilyl group binding to the SiO2 surface.  X-ray photoelectron spectroscopy 
(XPS) provides both quantitative and qualitative understanding of the sequential 
differential functionalization process.      
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4.3 Materials and methods 
Phenyl phosphonic acid (PPA; 98%) and N,O-
bis(trimethylsilyl)trifluoroacetamide (BSTFA; liquid) were purchased from Aldrich 
and were used as received.  Pure SiO2 and TiO2 nanoparticles and SiO2/TiO2 mixed 
nanoparticles with different mole ratios of Si versus Ti were synthesized via an 
aerosol phase route according to a previously reported method.9  Briefly, liquid 
precursors for SiO2 and TiO2, C6H18OSi2 (98+%, Aldrich) and TiCl4 (99.9%, Cerac) 
respectively, were vaporized by sparging with nitrogen and were carried to a high 
temperature (~2300 K) premixed methane, nitrogen/ oxygen flame reactor to generate 
the metal oxide nanoparticles.  In the flame, the precursors rapidly oxidize and the 
particles form by gas-to-particles conversion.  The flow rates of the two precursors 
were controlled for the generation of SiO2/TiO2 mixed nanoparticles at a mole ratio of 
Si versus Ti being roughly 5:1, 1:1, and 1:5.  In each flame synthesis of the pure and 
composite particles, the total concentration of Ti and Si in the flame was maintained 
at 1.3 × 10-4 mol/L of flame gas at standard temperature and pressure.  
Scheme 4.1 demonstrates reaction schemes for reactions of SiO2 and TiO2 
nanoparticles, and SiO2/TiO2 mixed nanoparticles.  The metal oxide nanoparticles 
(MONPs) were reacted first with phenyl phosphonic acids (PPA) in an aqueous 
solution (MeOH:H2O = 4:1, v/v; pH 4) using the reported preferential binding of 
phosphonic acids on TiO2 versus SiO2.6-8  BSTFA, a mild silylating agent, was used 
in the next step of silanation of the PPA-reacted MONPs (MONP-PPA).   
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Scheme 4.1  Scheme of differential functionalization of SiO2, TiO2, and SiO2/TiO2 
mixed nanoparticles.  
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Selective modification of SiO2/TiO2 mixed nanoparticles with PPA:  An aqueous 
PPA solution was prepared by adding PPA to a mixture of methanol and water 
(MeOH:H2O = 4:1 v/v) at 4 mM concentration and adjusting the pH to pH 4.  SiO2, 
TiO2 and SiO2/TiO2 mixed nanoparticles were added to the PPA solution at 1.0 
mg/mL concentration.   
After sonication for 10 minutes, the particle-suspended PPA solution was 
stirred for 15 hours at room temperature.  The PPA-reacted MONPs were collected by 
centrifugation and washed several times thoroughly with mixed solvent of methanol 
and water (4:1, v/v).  The washed nanoparticles were dried at 120 OC for 15 hours in 
vacuum.   
 
Silanation with BSTFA:  Nanoparticles were added to a round bottomed flask and 
nitrogen was purged to create an inert environment for silanation reaction.  Dried 
toluene was added at 10 mg nanoparticle/ mL toluene.  Nanoparticles were suspended 
by sonicating for 10 minutes.  Then, BSTFA was added at a tenth of the added 
toluene volume. The particle-suspended BSTFA solution in toluene was stirred for 2 
hours at room temperature.  The reacted nanoparticles were centrifuged and washed 
five times with toluene.  The washed particles were dried at 120 OC overnight in 
vacuum.   
  
XPS analysis:  XPS analysis is described in the methods section of Chapter 3.  
Nanoparticles were made in pellet form without any additives for XPS scans to 
minimize background interference from carbon tape.   
  63 
 
4.4 Results and discussion 
Figure 4.1 shows morphologies of SiO2, TiO2, and SiO2/TiO2 mixed 
nanoparticles at a mole ratio of Si to Ti being 5:1, 1:1, and 1:5 and a TEM image of 
SiO2/TiO2 mixed nanoparticles (Si:Ti = 1:1).  The interface between Ti-rich and Si-
rich domain shows curvature arising from the difference in surface energies of SiO2 
and TiO2, 0.3 and 0.5 J m-2 respectively.9  In a previous report on SiO2/TiO2 mixed 
particle synthesis, evidence of Si-O-Ti bonding was detected at 960 cm-1 in Fourier 
transform infrared spectra of the mixed nanoparticles.9  TEM images of SiO2/TiO2 
nanocomposites with three different mole ratio between Si and Ti are shown in Figure 
4.2.  The particle size is in the range between 10 and 50 nm.9  
Figure 4.3 displays XPS-scanned atomic concentrations (%) of Si and Ti, and 
the ratio of atomic concentration of Si/Ti of bare unreacted MONP, MONP-PPA, and 
BSTFA-reacted MONP-PPA (MONP-PPA-BSTFA).  Mole ratios of Si vs. Ti of SiO2 
nanoparticles, SiO2/TiO2 mixed nanoparticles, and TiO2 nanoparticles are controlled 
in the particle synthesis step as Si:Ti = 1:0, 5:1, 1:1, 1:5, and 0:1 respectively.  XPS-
mediated Si atomic concentration (%) of nanoparticles from SiO2, via SiO2/TiO2, to 
TiO2 nanoparticles is decreased from 27 to 18, 17, 3.7, and 0, while Ti atomic 
concentration (%) is increased from 0 to 2.6, 5.9, 10, and 19 respectively.  The 
corresponding XPS-determined atomic concentration ratio of Si vs. Ti is 3.9:1, 2.4:1, 
and 1:2.9 in the order of increased Ti portion in the mixed nanoparticles.  This ratio is 
roughly maintained in the XPS analysis of MONP-PPA and MONP-PPA-BSTFA 
(Figure 4.3).   
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Figure 4.1  (a) Morphologies of SiO2, TiO2, and SiO2/TiO2 mixed nanoparticles used 
in this work.  (b) TEM of SiO2/TiO2 (Si:Ti = 1:1) mixed nanoparticles.
1:0 1:51:15:1
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Si:Ti
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0:1
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10~50 nm
(b) 
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100 nm
100 nm
100 nm
(a) (b)
(c)
Figure 4.2 TEM of SiO2/TiO2 nanocomposites at different ratios of Si and Ti.  
The dark portion is TiO2.  (a) Si:Ti = 5:1, (b) Si:Ti = 1:1, (c) Si:Ti = 1:5.  
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Figure 4.3  Atomic concentration (%) of (a) Si and (b) Ti, and (c) the ratio of Ti 
versus Si atomic concentration in the XPS based upon analysis of SiO2, TiO2, and 
SiO2/TiO2 mixed nanoparticles.   
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The discrepancies of the XPS-determined ratios from the mole ratios in 
particle synthesis step are likely coming from three factors: i) In the particle synthesis 
process, there is some uncertainty in the flow rates of the precursors.  Since the 
precursor delivery rate was measured gravimetrically, 5-10% of uncertainty is 
involved in determination of the precursor flow rates. ii) As the TEM image in Figure 
4.1(b) shows, SiO2/TiO2 mixed nanoparticles with a mole ratio of Si:Ti = 1:1 do not 
display a perfect hemispherical-split but rather a bigger surface area of SiO2.  Since 
SiO2 (0.3 J m-2) has lower surface tension than TiO2 (0.5 J m-2), SiO2 may wet and 
have more surface area.  iii) Because of the surface-sensitive character of XPS, XPS-
mediated determination of the Si/Ti ratio is likely to be different from the bulk ratio.  
When the XPS signal detector is normal to the sampling surface as the case in this 
research, the escape depth of photoelectrons is given as three times the photoelectron 
mean free path.  The photoelectron mean free path is ~1.5 nm for both Si and Ti, 
which leads to the value of the escape depth being ~4.5 nm.  Considering the size 
range of the nanocomposites between 10 and 50 nm, the XPS results can be 
considered to be surface-specific rather than a determination of the bulk chemical 
composition of the nanocomposites.   
Figure 4.4 shows the phosphorous 2p region of bare MONPs and MONPs-
PPA.  Phosphorous can be used as an indicator of PPA binding to MONPs, since 
phosphorous does not exist on bare MONPs used in this work.  As expected, 
phosphorous of bare unreacted MONPs is not detected in the P 2p region of XPS.   
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Figure 4.4  Phosphorous 2p region of XPS scan of (a) SiO2 nanoparticles, (b)-(d) 
SiO2/TiO2 mixed nanoparticles, and (e) TiO2 nanoparticles.  A: Bare unreacted 
nanoparticles, B: Nanoparticles after reaction with phenyl phosphonic acid (PPA).  
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After reaction of SiO2 nanoparticles with PPA, no peak in the P 2p region of XPS is 
seen.  However, when mixed SiO2/TiO2 nanoparticles were reacted with PPA, a 
distinctive P 2p peak appeared at around 134 eV.100, 144  In general, the P 2p peak 
grows in intensity and signal to noise ratio as the mole ratio of Ti versus Si is 
increased.  Comparison of the P 2p XPS spectra before versus after PPA reaction 
clearly demonstrates selective phosphonic acid-binding to TiO2 of the mixed surfaces 
under aqueous reaction conditions.  This preferential binding is  due to the higher 
stability of Ti-O-P bonds to hydrolysis than Si-O-P bonds in an aqueous 
environment.6, 99, 101  Si-O-P bonds are formed in organic solvents.  In previously 
published reports, SiO2-phosphonic acid peaks were detected in 31P solid-state NMR 
spectra in an organic aprotic solvent such as hexane145 or toluene6.  However, the 
phosphorous peaks disappeared under aqueous reaction conditions due to the labile 
nature of Si-O-P bonds to hydrolysis.6, 99  Schematic representations of PPA reaction 
with TiO2 and SiO2 surfaces are given in Schemes 4.2 (b) and 4.3 (b).  The TiO2-PPA 
binding mode is described as predominantly tridentate (RP(OTi)3 species) by 17O 
solid-state NMR spectra146 and 31P solid state NMR spectra study6.  The tridentate 
binding of PPA to TiO2 surface modifies coordination number of Ti atoms on the 
surface, whereas trimethyl silyl group-binding by BSTFA reaction does not (Scheme 
4.2).  In a report of the use of PPA to modify TiO2 surfaces, this modified 
coordination number of Ti led to a reduced catalytic activity of the PPA-bound TiO2 
surface due to decreased Lewis acid character.6   
A minor peak of 31P solid state NMR spectra of TiO2-PPA was assigned to the 
presence of the surface-bound phosphonic acids with other binding modes or in a 
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distorted geometry.6, 146  These features likely lead to the appearance of another pair 
of Ti 2p peak of small intensity in XPS of TiO2-PPA, while trimethyl silyl group 
binding to TiO2 nanoparticles does not change the shape and the position of Ti 2p 
peaks (Figure 4.5).   
   Figure 4.6 shows the atomic concentration (%) of the P 2p peaks and the 
ratio of atomic concentration of P 2p peak/Ti 2p peaks of MONP-PPA and MONP-
PPA-BSTFA respectively.  The atomic concentration (%) of P of MONP-PPA grows 
from 0 for pure SiO2 nanoparticles to 0.19, 0.17, and 0.99 with the increasing 
percentage of surface Ti atoms of the mixed nanoparticles (Figure 4.6(a)).  The P 
atomic concentration of pure TiO2 nanoparticles is 0.84%.   
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Scheme 4.2  Schematic representation of surface modification of TiO2 nanoparticles 
with (a) BSTFA and (b) PPA. 
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Scheme 4.3  Schematic representation of surface modification of SiO2 nanoparticles 
with (a) BSTFA and (b) PPA. 
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Figure 4.5  Ti 2p XPS spectra of (a) bare unreacted TiO2, (b) BSTFA-reacted TiO2, 
and (c) PPA-reacted TiO2 nanoparticles.   
460 456 452
Binding energy (ev)
464468
(a) TiO2
(b) TiO2
-BSTFA
(c) TiO2
-PPA
  74 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6  (a) Atomic concentration (%) of phosphorous 2p (P 2p) peaks and (b) the 
ratio of atomic concentration of  P peaks versus atomic concentration of Ti peaks.    
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Figure 4.7  (a) Atomic concentration (%) of carbon 1s (C 1s) peaks and (b) the atomic 
concentration ratio of C 1s peaks versus (Si 2p + Ti 2p) peaks.    
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When the atomic concentration of the P 2p peak is divided by the atomic 
concentration of the Ti 2p peak, the XPS data in scanning of phosphorous are more 
comparable with each other as the Ti 2p peak can be used as an internal standard.  On 
average, 0.05 phosphorous atoms are bound per one Ti atom (Figure 4.6(b)).  The 
binding number of P per Ti is 0, 0.050, 0.021, 0.099, and 0.044 as the presence of Ti 
on the nanoparticles is increased from SiO2 to SiO2/TiO2 and TiO2 nanoparticles.  
Considering the dominant tridentate binding nature of PPA to TiO2 and the binding 
ratio of P/Ti being 0.044, the percentage of Ti occupied by PPA is 13% on TiO2-PPA.  
Fluctuation of the ratio is likely from different initial conditions of the particles, for 
example different amount of carbon contamination on bare unreacted nanoparticles 
(Figure 4.7(a)).  In the case of mixed nanoparticles of mole ratio of Si:Ti = 5:1 and 
1:5,  the binding ratio of P/Ti (0.050 and 0.099) is greater than the ratio of pure TiO2 
nanoparticles (0.044).  This observed phenomena can be partially ascribed to the 
formation of P-O-Si bonds at the SiO2-TiO2 interface of SiO2/TiO2 mixed 
nanoparticles (Scheme 4.4).6 
 
 
 
Scheme 4.4  Formation of phenyl-P(OTi)2(OSi) bonds at the interface of TiO2 and 
SiO2 portion of SiO2/TiO2 mixed nanoparticles.  
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Mutin et al.6 reported a significant increase of peak width from TiO2-PPA 
surface to SiO2/TiO2-PPA surface in their 31P solid state NMR spectra.  In their 
hypothesis, the increased peak width was explained by the formation of P-O-Si bonds 
during the drying process at the boundary between SiO2 and TiO2 in addition to the 
formation of P-O-Ti bonds (Scheme 4.4).  This hypothesis was proved by a 
significant suppression of the 31P NMR peak due to hydrolysis of some of the P-O-Si 
bonds, when the phosphonic acid-bound SiO2/TiO2 surface was immersed in a 
mixture of methanol and water.  The presence of P-O-Si bonds was also used to 
explain larger surface coverage (25%) by phosphonic acids on phosphonic acid-
reacted SiO2-TiO2 surface than the actual mole percentage of Ti (10 mole %) on the 
mixed surface.  
The phosphorous peak is maintained after silanation reaction with BSTFA, 
though atomic concentration ratio of P/Ti is decreased by 20% ± 10% on mixed 
nanoparticles (Figure 4.6(b)).  This decrease can be explained by the combined effect 
of the following: (i) The hydrolysis of the Ti-O-Si bond may lead to instability and 
even destruction of PPA binding at the interface between SiO2 and TiO2 and 
elimination of PPA on the surface of TiO2.  The higher retention of PPA binding to 
pure TiO2 nanoparticles after the BSTFA treatment demonstrates that the tridentate 
binding mode between PPA and the TiO2 surface contributes to the stability of the 
bonds.  (ii) Suspension in an organic solvent, toluene, can displace the phosphorous 
bonding.  The effect of toluene in the step of BSTFA reaction was investigated.  
TiO2-PPA particles were suspended in toluene without the addition of BSFTA for the 
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same time as in the case of BSTFA reaction and characterized with XPS.  The results 
are shown in Table 4.1.   
 
Table 4.1 Effect of solvent (toluene) in the BSTFA reaction step: atomic 
concentration (%). 
 
 
 
Before toluene treatment 
 
After toluene treatment 
Ti  14.2 ± 1.4 
 
14.8 ± 1.5 
P 0.66 ± 0.07 0.61 ± 0.06 
P/Ti 0.047 ± 0.005 0.041 ± 0.004 
 
 
Phosphorous binding was decreased 12% after suspension in toluene.  
Loosely-bound PPA in mono- and bi-dentate binding mode and in distorted tri-
dentate binding mode was likely displaced in suspension in an organic solvent.   
Organosilanes such as BSTFA bind to both SiO2 and TiO2 surfaces.  Si was 
not detected on bare TiO2 and TiO2-PPA in XPS spectra (Figure 4.3).  Trimethyl silyl 
group binding to TiO2-PPA in BSTFA reaction led to the appearance of Si 2p peaks 
at a Si/Ti ratio of 0.16.    
 Figure 4.7 demonstrates XPS results for the carbon 1s region of MONP, 
MONP-PPA, and MONP-PPA-BSTFA.  Bare MONPs display carbon 
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contaminations.100, 108, 147  Intensive cleaning of the TiO2 surface did not remove 
carbon contamination completely in a previous report of XPS characterization, since 
carbon contamination is unavoidable in practice on ambient air-exposed inorganic 
surfaces.100  In general, the amount of carbon contamination increases from 4.8% of 
atomic concentration up to 25%, as the Ti portion increases from SiO2 to SiO2/TiO2, 
and to TiO2 nanoparticles.  Increase of surface-bound carbon is evident in PPA-
reacted SiO2/TiO2 (Si:Ti = 1:5) mixed nanoparticles because of the largest amount of 
P at a ratio of P/Ti being 0.099 (Figure 4.6(b)).  Binding of PPA accounts for the 
increase of 0.6 carbons per Ti out of the observed increase of 1.4 carbons per Ti.  The 
other portion of carbon increase on the mixed particles along with increase of carbon 
from 0.18 to 0.47 carbons per Si on SiO2 nanoparticles is likely from adsorption of 
methanol from solution.  The lack of a distinctive increase in carbon on the surface of 
other particles may be attributed to the uncertainty involved with different amounts of 
carbon contamination.  Pure nanoparticles demonstrate noticeable trimethyl silyl 
group binding to MONP-PPA, as the C/Si ratio is increased from 0.47 to 0.99 on SiO2 
nanoparticles and from 1.3 to 4.5 on TiO2 nanoparticles.  0.5 out of the 3.2 carbon 
number increase per Ti on TiO2 nanoparticles is attributed to the presence of 
trimethyl silyl binding, since the Si/Ti ratio was increased from 0 to 0.17 (Figure 4.3).  
The other portion of the increase may be related to physisorption of BSTFA, 
degraded parts of BSTFA, and toluene.   
 Note that a minor pair of peaks appears on a Ti 2p peak scan of TiO2-PPA 
compared with the peak of bare TiO2, while XPS spectra of TiO2-BSTFA in the Ti 2p 
region does not exhibit any change in peak shape. (Figure 4.5)  A similar trend is 
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observed with Ti 2p spectra of SiO2/TiO2-PPA and SiO2/TiO2-PPA-BSTFA (Figure 
4.8).  A pair of minor peaks, a 2p 3/2 peak and a 1/2 peak of Ti, vanishes with 
BSTFA reaction.  In addition to the partial hydrolysis of P-O-Si bonds addressed 
previously in the text, this phenomenon likely accounts for the displacement of 
loosely bound PPA molecules with bond modes other than undistorted tridentate 
binding and with distorted bonds, as discussed in the description of the 12% decrease 
of P/Ti ratio by suspension of TiO2-PPA in toluene.      
 
 
 
 
Figure 4.8 Ti 2p spectra of SiO2/TiO2 mixed nanoparticles. Si:Ti = 5:1 (A), 1:1 (B), 
and 1:5 (C).  
A CB
460 456 452464468
Binding energy (ev)
460 456 452464468
Binding energy (ev)
460 456 452464468
Binding energy (ev)
MONP
MONP-PPA
MONP-PPA
-BSTFA
MONP
MONP-PPA
MONP-PPA
-BSTFA
MONP
MONP-PPA
MONP-PPA
-BSTFA
  81 
 
4.5 Conclusions 
This study demonstrates differential functionalization of SiO2/TiO2 mixed 
nanoparticles via a preferential binding of PPA to TiO2 portion in an aqueous solution 
and a subsequent reaction of trimethyl silyl groups to the remaining surface.  For 
understanding of the effect of surface portion of TiO2 on differential functionalization, 
three different SiO2/TiO2 mixed nanoparticles were used with approximate mole 
ratios of Si:Ti = 5:1, 1:1, and 1:5.  XPS analysis of Si 2p and Ti 2p region displays 
mole ratios of Si:Ti =  3.9:1, 2.4:1, and 1:2.9 respectively.  The differences likely 
arise from uncertainties in determination of mole ratios in particle generation step, the 
fact that XPS investigates surface rather than bulk chemical compositions of the 
materials, and possibility of interferences from carbon tape background.  Detection of 
a P 2p peak after PPA reaction can be convincing evidence of PPA binding to the 
surface, since a P 2p peak does not appear in bare unreacted particles.  PPA-reacted 
SiO2 particles do not exhibit a P 2p peak, whereas all the other TiO2-included 
particles display the appearance of a P 2p peak in XPS spectra after the reaction with 
PPA.  This preferential binding of PPA to TiO2 vs. SiO2 surface derives from the 
much higher stability of Ti-O-P bond to hydrolysis than Si-O-P bond.  The averaged 
number of binding of P per Ti is 0.05, which is accountable for 0.15 carbon binding 
per Ti in consideration for previously reported tridentate binding mode of PPA to 
TiO2.  After trimethyl silyl group binding to the surface, the P/Ti ratio is retained at 
80% ± 10% for SiO2/TiO2 mixed nanoparticles, while 98% of P/Ti ratio of TiO2 
nanoparticles is maintained.  The displacement of P at 20% ± 10% level for the mixed 
nanoparticles is likely due to existence of Si-O-P bonds at the interface between SiO2 
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and TiO2 and hydrolysis of the labile bond in silanation, along with removal of 
loosely bound PPA.  Si 2p XPS spectra of TiO2 nanoparticles demonstrates trimethyl 
silyl group binding to PPA-reacted TiO2.  In addition to this silanation to TiO2, C 1s 
spectra and Ti 2p spectra are indicative of trimethyl silyl group binding to the mixed 
nanoparticles.  A variety of phosphorous compounds containing terminal functional 
groups such as –OH,100, 101 -SH,148 and –COOH149, 150 are available.  The 
demonstrated differential functionalization of SiO2/TiO2 nanoparticles herein and the 
presence of diverse functional phosphorous compounds together with well-
established silanation chemistry provide a promising opportunity for the use of the 
mixed nanoparticles as multifunctional nanoparticles for biological applications.    
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Chapter 5:  X-ray scattering study of the interactions between 
magnetic nanoparticles and living cell membranes 
 
 
5.1 Abstract 
Magnetic nanoparticles (MNPs) have found increased applicability in drug 
delivery, cancer treatment, and immunoassays.  There is a need for an improved 
understanding of how MNPs interact with living cell membranes in applied magnetic 
fields to use them effectively.  The interactions between Escherichia coli (E. coli) and 
SiO2/γ-Fe2O3 composite particles in magnetic fields were studied using X-ray 
scattering (XRS).  Magnetic field strengths up to 423 mT were applied to the samples 
to see the effects of the magnetic fields on the E. coli membranes in the presence of 
the magnetic particles in the cell cultures.  X-ray scattering results from continuous 
cultures of E. coli showed two peaks, a sharp peak at q = 0.528 Å-1 (1.189 nm) up to 
362 mT of magnetic field strength and a diffuse one at q = 0.612 Å-1 (1.027 nm).  The 
sharp peak was shifted to the smaller side of q when magnetic particles were added 
and the magnitude of the applied magnetic field strength was increased from 227 mT 
to 298 mT, to 362 mT, whereas the diffuse peak did not change.  A critical magnetic 
field strength at which the sharp peak disappears was found at 362 mT. 
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5.2 Introduction 
The interactions between magnetic nanoparticles (MNPs) and cells in 
magnetic fields must be understood to learn to control technologies important to the 
fields of medicine and biotechnology.122, 134, 135, 151-156   Such applications include the 
ability of the MNPs to be used to deliver drugs effectively or to kill tumor cells by 
local heating from an alternating current magnetic field.122, 152-154  Physical model 
systems using phospholipid bilayers mimicking a cellular membrane have been 
investigated to understand the interactions between MNPs and the lipid bilayers.10, 157-
161  In studies using a lyotropic lamellar phase, a periodic stack, which ranged from 
20 to 40 nm in thickness with water and a suspension of γ-Fe2O3 nanoparticles in 
cyclohexane, was observed.157-159, 161  Particles adsorbed on the membranes rotated in 
the presence of a magnetic field, which resulted in a distortion of the lamellar 
structure.  A change in birefringence was determined using a polarizing microscope157 
or a polarized He-Ne laser,161 whereas X-ray scattering was used to measure the layer 
separation and the rotation angle of the layer molecules in the changing magnetic 
field.10  This rotation of the lipid layers could potentially be done with the lipid layers 
that constitute the cell membranes or walls. 
       Escherichia coli (E. coli) belongs to the class of gram negative bacteria, which 
have an outer membrane as well as a plasma membrane.  The lipid membranes 
extracted from E. coli cellular membranes have been of great interest, and have been 
used as a model system to test different interactions.  X-ray scattering (XRS) was one 
of the important tools to investigate the property of the lipid membranes extracted 
from E. coli.162-168  In their paper, Esfahani et al.162 found that studies of extracted 
  85 
 
lipid membranes give results that are different from those of the lipid components of 
intact membranes due to the presence of proteins and other structural molecules in 
intact membranes. Recently, the interaction of gramicidin, an antimicrobial peptide, 
with the lipid bilayers membranes generated from E. coli membrane lipids was 
investigated using X-ray scattering along with 31P-NMR.169, 170  A study of the 
interactions between MNPs and E. coli cellular membranes has not been reported to 
date.  A study of living cells is needed to determine the effectiveness of using MNPs 
to deliver drugs or to kill tumor cells.122, 152-154  In this work, the cellular membranes 
of living cells, E. coli, were studied instead of artificial phospholipid bilayers or 
membranes of lipids extracted from the cells.  X-rays were employed as a tool to 
understand changes in the E. coli membrane bilayers with SiO2/γ-Fe2O3 composite 
nanoparticles under the influence of the applied magnetic fields.  
 
5.3 Methods 
5.3.1 Magnetic nanoparticles 
The unagglomerated SiO2/γ-Fe2O3 particles were synthesized from 
hexamethyl disiloxane and iron pentacarbonyl via a gas phase approach in a premixed 
aerosol flame reactor, where Si and Fe were mixed at a 1:1 mole ratio.9  A 
transmission electron microscope image of a typical particle is shown in Figure 5.1.  
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The dark region corresponds to iron oxide (γ-Fe2O3) whereas the light region is 
amorphous silica.  The iron oxide portion of the particle imparts magnetic properties, 
whereas the silica surface provides the particle with the potential for surface 
modification.  SiO2/γ-Fe2O3 composite particles were used as MNPs, ranging from 20 
to 100 nm in particle size.  The distribution of particle sizes as measured by TEM can 
be seen in Figure 5.2a.  The particles were sonicated to reduce agglomeration before 
being added to the growth medium of E. coli.  According to dynamic light scattering, 
they likely agglomerate again as a function of time during the course of the 
experiment (see Figure 5.2b).  Scattering from the cell in the region between 9 and 20 
nm due to the presence of the particles is investigated.  The experiments do not 
measure interactions at the 400 nm level.  
  
100 nm
Figure 5.1  Transmission electron microscope image of a SiO2/γ-Fe2O3 particle.  
The dark region of the particle corresponds to γ-Fe2O3 and the light region is 
amorphous silica.  
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Figure 5.2  (a) Distribution of particle sizes as measured using TEM.  (b) 
Agglomeration of the particles as a function of time in the M9 medium.   
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Batch cultures of E. coli were performed in our group to see if the SiO2/γ-
Fe2O3 particles have any inhibitory effect on the growth of the cells.  According to the 
results171 not presented here, these particles have no measurable effect on the growth 
of E. coli up to the particle concentration of 44 mg l-1.  The final concentration of the 
particles in this report was 40 mg l-1 in E. coli growth medium, taken under the 
maximum particle concentration in the toxicity test of the particles upon E. coli.  
 
5.3.2 Biological system 
   The bacteria were grown at 37 OC in modified M9 medium, where amounts 
of Ca and Mg in the medium were doubled to those in M9 medium, in both batch and 
continuous cultures.172  Ampicillin was added to each medium at the final 
concentration of 100 µg ml-1 to keep the sterility of the culture.172  The optical density 
(Absorbance reading at 600 nm) of E. coli was 1.8 ± 0.5 both in batch and continuous 
cultures, when samples were taken for the X-ray scattering.  For the continuous 
cultures of E. coli, the cells were grown in a working volume of 250 ml in a 500 ml 
three necked round bottomed flask.  A batch culture of the E. coli was performed for 
the purpose of attaining the maximum specific growth rate of the strain.  The 
maximum rate was determined to be 0.90 hr-1. A dilution rate of 0.4 hr-1 (flow rate of 
100 ml hr-1) was used below the maximum specific growth rate in the continuous 
growth of the E. coli to avoid washout of the cells.116  This amplitude of flow rate in 
continuous cultures and in situ X-ray scatterings is enough to give a mixing effect to 
the mixture in the vial so that the cells are kept in suspension and in homogeneous 
condition in the vial.  An overhead mechanical stirrer with a Teflon blade 
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(Chemglasss, Vineland, New Jersey) was used as an agitator rotating at 300 rpm.  
Filtered air was provided at 3 vvm. pH remained at 7, not changing much during the 
cultures.   The exiting culture out of the reactor was pumped to a glass vial to take an 
XRS. A schematic diagram of the continuous cultures of E .coli and in situ 
measurement of XRS is shown in Figure 5.3.  Growth studies on E. coli after 
exposure to the X-rays are given in Appendix C.5.  In brief, no adverse effects of the 
X-rays on cell culture health were observed. 
 
 
 
 
 
 
 
 
5.3.3 X-ray scattering system 
The X-ray machine is a Rigaku 18 kW rotating anode source with a Cu 
source.  The 1.54 Å line was chosen by a bent graphite monochromator, which has a 
resolution of ∆q = 0.017 q0 at  FWHM.  The beam was controllable by shutters, which 
were set at 1 x 0.2 cm2.  The power used was the maximum at 60 kV times 300 mA in 
in-situ X-ray scattering from continuous cultures of E. coli in the presence of the 
magnetic particles.  A power of 50 kV times 100 mA was used in the other cases.  It 
Figure 5.3  A schematic diagram of (a) the continuous culture of E. coli and  
(b) the in situ x-ray scattering. 
Water 
Bath
M9 medium
with/without
MNPs
Air
X-ray
Waste
(a) (b)
Magnets
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took forty seconds to obtain one scattering measurement.   A silicon standard was 
used to center the sample and make sure that the differences observed were due to the 
magnetic particles and not to a slide in the X-ray motors. 
         The X-ray scattering study was performed on a glass vial (Kimble glass, 
Vineland, NJ; 13.4 mm in diameter and 45 mm high) containing E. coli culture 
samples.  A permanent magnet, made of neodymium-iron-boron (Arbor Scientific, 
Ann Arbor, MI), in cylindrical shape, 2.2 cm in diameter and 2.6 cm in length, was 
placed on each side of the vial to apply a magnetic field to the system.  A holder was 
devised to fix the position of the vial and the two magnets, where the long axis of the 
vial and the directions of the magnetic field were orthogonal.  The position of the 
magnets could be adjusted to change the distance between the magnets and thus the 
magnetic field strength.  The distance between the two magnets was set using an 
aluminum bar with a predetermined width corresponding to a magnetic field strength 
(Figure 5.4).  227, 298, 362 and 423 mT were employed in batch and continuous 
cultures of E. coli.  Before each XRS scan was started, the magnetic holder was 
adjusted into a position such that the magnetic field lines between the two magnets 
were perpendicular to the X-ray beam line when the two theta angle is zero.  
Four types of XRS results were obtained depending on whether or not E. coli 
was cultured with MNPs and whether or not the XRS of a sample was measured in a 
magnetic field, which are as follows: (1) XRS of an E. coli culture, (2) XRS of E. coli 
cultured with MNPs, (3) XRS in a magnetic field of an E. coli culture, and (4) XRS in 
a magnetic field of E. coli cultured with MNPs.  
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Figure 5.4  Magnetic field strength as a function of the distance between the two 
magnets.  Field strengths of 227, 298, 362, and 423 mT were used in the experiments.  
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5.3.4 Transmission electron microscope (TEM) images 
The interactions between the cells and the nanoparticles were observed using 
a Zeiss EM10 CA microscope at the Univerisity of Maryland Biological 
Ultrastructure Facility.  Samples of E. coli were withdrawn at points during late 
exponential phase, where the optical density at 600 nm was about 0.6.  After 
collection, they were centrifuged and suspended at room temperature in 0.12M 
Millonig’s phosphate buffer at pH 7.3 and later with 2% glutaraldehyde.  The cell 
pellets were then washed again with the buffer, and then the secondary fixation of the 
cells was performed with 1% OsO4.  At this point, they were washed with distilled 
water and then postfixed with 2% uranyl acetate, rinsed in the buffer and double 
distilled water, dehydrated in a series of ethanol and propylene oxide immersions, and 
embedded in Spurr’s resin.  A diamond knife was used to section the embedded cells.  
The sections were post-stained with 2.5% aqueous uranyl acetate and 0.2% aqueous 
lead citrate.   
 
 
5.4 Results and Discussion 
Two X-ray scattering studies were performed: one in batch grown E. coli and 
one in continuous cultures.  The results from the batch grown sample were difficult to 
assess, because the sample tended to settle at the bottom of the vial, introducing a 
non-homogeneity in the solution.  A solution measured with no magnetic field varied 
from one measured for example at 362 mT, and one measured without MNPs differed 
from one with MNPs but it could not be determined if it was due to the 
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inhomogeneity or the presence of the MNPs.  Therefore, the changes could not be 
exactly measured from one magnetic field to another or from one sample to the next. 
 In situ measurement of X-ray scattering using continuous cultures of E. coli 
was tried as an alternate to the batch cultures, for continuous cultures make it easier to 
maintain steady state growth conditions including the cell concentration among the 
measurements by controlling the dilution rate.  Reproducible results were obtained 
using this approach.  Because the E. coli sample is being continuously renewed, the 
MNP’s are not allowed much time to agglomerate.  
 Figure 5.5a shows the X-ray scattering taken of the E. coli corresponding to 
the continuous cell culture alone, without the MNPs. In a study of E. coli membranes, 
Esfahani et al.162 identified a diffuse band at 0.34 nm (3.4 Å), a sharp band at 0.42 nm 
(4.2 Å) and a diffuse band at 1.05 nm (10.5 Å).  The low angle (1.05 nm) corresponds 
to the long range organization173 of the hydrocarbon chains that make up the 
membrane. From Figure 5.4a, two peaks are resolved in this region, a sharp peak 
corresponding to q = 0.528 Å-1, which corresponds to a separation of 1.189 nm (11.89 
Å), and a diffuse one at 0.612 Å-1, which corresponds to the diffuse peak reported by 
Esfahani et al.162  The peak at 0.528 Å-1 or 1.189 nm probably corresponds to a lower 
reflection of the 0.42 nm sharp peak which corresponds to the lipid membrane.  
Figure 5.5a shows the four different magnetic fields applied in the experiments: 227, 
298, 362 and 423 mT.  None of the peaks are affected by the application of the 
magnetic fields, except the one at q = 0.534 Å-1 at 423 mT.  
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Figure 5.5  In situ X-ray scattering results from E. coli continous cultures (a) in the 
absence and (b)-(d) in the presence of the magnetic particles (three repeated 
experiments).  q = 4π sin θ/λ.
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             Figure 5.5 b-d show the effect of adding the magnetic nanoparticles to the 
cultures.  Figures 5.5c and 5.5d are repeats of the same experiment in Figure 5.5b.  
The peak at 0.528 Å-1 shifts to 0.485 Å-1, which corresponds to 1.296 nm (12.96 Å).  
This suggests an interaction of the cell and the magnetic particles, because of the 
magnetic field produced by the particles, without the application of the magnetic 
field.   Note that the 0.612 Å-1 peak does not change position.  The effect of the 
magnetic particles is summarized in Table 5.1 and Figure 5.6.  At 362 mT, the peak 
oscillates in value as seen in Figure 5.6, whereas the peaks for the other magnetic 
fields remains constant, as seen from Figure 5.5 b–d.  Therefore, it is a conclusion 
that 362 mT represents a critical field.  The 0.612 Å-1 peak does not change, probably 
because it is not a signal due to the lipids in the membranes.162  
Figure 5.7 shows two TEM images of E. coli and the magnetic nanoparticles. 
Note that not all the cells have magnetic particles in the vicinity, but the ones that 
have show that the particles are in contact with the cells.  Figure 5.7b suggests that 
maybe the particles are attaching themselves through the SiO2 portion, which is the 
more biologically compatible part of the nanoparticles.  The TEM images confirm 
that the X-ray scattering is looking at the particle-cell interactions.  The fact that the 
magnetic nanoparticles are not functionalized suggests that surface modification of 
the MNPs may have a greater impact on the structure and the interactions with the 
cellular membrane.  An indication that this is the case happens when the E. coli was 
mixed with 10nm FeCo particles that have been functionalized with polyethylene 
glycol.  A new peak corresponding to 1.672 nm (16.72 Å) appeared.174  Fe3O4 
particles covered with gum arabic and mixed with E .coli also indicate this.171  
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Table 5.1  Peak positions as a function of the presence of the particles and applied 
magnetic field strengths.  
 
 
 
 
 
                 
                Peak 1                 Peak 2 
 q (Å-1) d (Å) q (Å-1) d (Å) 
E. coli, 0 mT 0.528 11.89 0.612 10.27 
E. coli and MNPs, 0 mT 0.485 12.96 0.612 10.27 
E. coli and MNPs, 227 mT 0.485 12.96 0.612 10.27 
E. coli and MNPs, 298 mT 0.485 12.96 0.612 10.27 
E. coli and MNPs, 362 mT 
 
 
0.481 
0.485 
0.459 
N/A 
13.09 
12.96 
13.68 
N/A 0.612 10.27 
E. coli and MNPs, 423 mT N/A N/A 0.612 10.27 
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Figure 5.6  Peak position as a function of the applied magnetic field strengths. 
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Figure 5.7 Transmission electron micrograph images showing that E. coli have 
contacts with the SiO2/γ-Fe2O3 particles.  Arrows point out contacting parts 
between the cell and the particles.  (a)  An E. coli cell surrounded by the magnetic 
particles.  (b)  A magnetic particle is in contact with the E. coli membrane.  
100 nm
0.5 µm
(a)
(b)
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An XRS study was conducted to investigate the effect of MNP concentration up to 
100 mg l-1 to the peak shifts.  Effects of divalent ions such as Ca2+, Mg2+, and SO42- in 
cell culture medium on XRS-detected peak shifts were also studied.  The XRS data 
are presented in Appendix C.6 with a brief discussion of the results.   
 
5.4 Conclusions 
X-ray scattering was performed on continuous cultures of E. coli cells, which 
are grown in the absence/presence of SiO2/γ-Fe2O3 composite particles which are 
magnetic particles.  This study of the interactions between E. coli and the MNPs 
using XRS provides insight on how the MNPs affect the membrane structure in the 
applied magnetic fields.  Magnetic fields up to 423 mT were applied on the cells, to 
observe the effect of the magnetic particles and the magnetic field strengths.  In situ 
X-ray scattering from continuous cultures gave significant differences, depending on 
whether or not the particles were included in the cell cultures.  Two peaks were 
observed in the in situ X-ray scatterings from continuous cultures of E. coli, a sharp 
peak at q = 0.528 Å-1 up to 362 mT of magnetic field strength and a broad one at q = 
0.612 Å-1 when the particles were not added to the cultures.  The sharp peak showed a 
change from q = 0.53284 Å-1 to q = 0.485 Å-1 when the particles were added, due to 
the effect of the magnetic field of the particles.  A critical magnetic field strength was 
observed at 362 mT, at which the value for the peak oscillates every time the 
experiment is repeated.  Beyond this field the sharp peak disappears and only the 
peak at 0.512 Å-1 remains.  TEM images of the cells grown in the presence of the 
particles showed that some cells had the magnetic particles in contact with the 
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membranes, which supports the suggestion that the changes in X-ray scattering comes 
from the interactions between the particles and the cell membranes.  Non-
functionalized particles were used in these experiments.  Modifying the particles with 
biofunctional molecules may cause larger differences in the X-ray scattering since the 
particles may be able to penetrate the E. coli. 
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Chapter 6:  Conclusions and recommendations 
 
6.1 Conclusions 
 Systematic studies of the functionalization of metal oxide nanoparticles for 
biological applications were conducted.  Hybridization of anti-mouse IgG on 
magnetic γ-Fe2O3 nanoparticles was achieved via silane chemistry with 3-
aminopropyl triethoxy silane and glutaraldehyde activation.  The bio-activity of 
immobilized anti-mouse IgG was evaluated by magnetic-field assisted sequestration 
of mouse IgG in solution with the anti-mouse IgG immobilized MNPs.  A 
chemisorption isotherm, obtained via fluorescence-based assays, provides a 
quantitative evaluation of anti-mouse IgG binding to the magnetic nanoparticles 
(MNPs).  The results show that anti-IgG binding is controlled stoichiometrically and 
the saturated surface coverage is ~36% of the theoretical limit.  This saturated binding 
corresponds to 34 randomly oriented anti-mouse IgGs per average size MNP with 32 
nm diameter.  Fluorescence spectroscopy analysis of magnetic field assisted-
sequestration of mouse IgG indicates that the hybridized anti-mouse IgG retains 
~50% of its bio-activity at saturation. 
 Differential functionalization of aerosol-phase synthesized SiO2/TiO2 mixed 
nanoparticles was demonstrated via an X-ray photoelectron spectroscopy study.  
Differential functionalization of the composite metal oxide-metal oxide nanoparticles 
was achieved using a sequential reaction of preferential binding of phenyl phosphonic 
acids (PPA) to TiO2 and subsequent binding of trimethyl silyl group to the remaining 
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SiO2 surface.  For comparative understanding of differential functionalization, 
SiO2/TiO2 mixed nanoparticles with three approximate mole ratios of Si:Ti = 5:1, 1:1, 
and 1:5 as well as pure SiO2 and TiO2 nanoparticles were used.  XPS results in the P 
2p region demonstrate that aqueous phase reaction of the nanoparticles with PPA 
leads to preferential binding of PPA to TiO2 vs. SiO2 surfaces.  This preferential 
binding of PPA to TiO2 is presumably due to much higher stability of the Ti-O-P 
bond to hydrolysis than the Si-O-P bond.  Tridentate binding mode of PPA on the 
bulk TiO2 is described as PhP(OTi)3, while the tridentate binding of PPA to the 
interface of SiO2-TiO2 is suggested as PhP(OTi)x(OSi)y (here, x + y = 3, and x = 1 or 
2).  XPS analysis infers that PPA binds to a surface of TiO2 at an averaged atomic 
ratio of 0.05 P/Ti.  The atomic ratio of P/Ti is retained at 80% ± 10% for SiO2/TiO2 
mixed nanoparticles after silanation reaction with a trimethyl silyl group binding.  
XPS spectra in the C 1s and Ti 2p regions are indicative of trimethyl silyl group 
binding to PPA-reacted nanoparticles.                 
 An X-ray scattering (XRS)-mediated technique for the study of interactions 
between E. coli cell membranes and magnetic nanoparticles was developed.  In situ 
XRS of E. coli in a magnetic field up 423 mT displays two peaks, a sharp peak at q = 
0.528 Å-1 (1.189 nm) up to 362 mT of magnetic field strength and a diffuse one at q = 
0.612 Å-1 (1.027 nm).  The presence of SiO2/γ-Fe2O3 magnetic nanoparticles at a 
concentration of 40 mg/L shifted the sharp peak to a smaller side of q as applied 
magnetic field is increased from 227 mT to 298 mT and up to 362 mT, whereas the 
diffuse peak did not change.  A critical magnetic field strength was 362 mT, at which 
the peak disappears.  
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These three research topics mentioned above are related to each other in the 
sense that these studies have advanced our knowledge of nanoparticle 
functionalization and biological applications of the nanoparticles.  The quantitative 
understanding of antibody immobilization on magnetic nanoparticles based on 
fluorescence assays can be applied to construct multifunctional nanocomposites with 
biological functional groups using Fe2O3, SiO2/Fe2O3 or SiO2/TiO2 
nanoparticles.  The detailed study of surface modification adopting XPS 
characterization in Chapter 4 is helpful for better understanding APTES modification 
of magnetic iron oxide nanoparticles in Chapter 3 and future surface modification of 
the magnetic nanoparticles.  These particles are aimed at applications in biological 
systems in the presence of biological cells such as E. coli., such as for a sensitive 
detection of biological cells and for drug delivery purposes.  The improved 
understanding of interactions between E. coli and SiO2/γ-Fe2O3 nanoparticles 
obtained via the X-ray scattering study in Chapter 5 will be helpful in engineering 
specific interactions between biological cells and the nanoparticles in those biological 
applications.  
 
6.2 Recommendations 
The technique described in Chapter 3 to evaluate surface coverage and bio-
activity of dye-labeled antibodies bound on MNPs is a general method and can be 
applied to any dye-labeled proteins of interest to quantify their surface coverage on 
MNPs after hybridization.   
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The quantitative understanding of antibody hybridization with magnetic iron 
oxide nanoparticles opens the possibilities for the use of these nanoparticles in 
biological applications such as magnetic resonance imaging and sensitive bio-
separation.  Control of antibody immobilization on magnetic nanoparticles may lead 
to the formation of multifunctional nanoparticles by attachment of other 
functionalities such as an poly(ethylene glycol) (PEG) moiety for an extended blood 
circulation in cancer therapy (Figure 6.1).11  Monodisperse magnetic nanoparticles 
(MNPs) with diameters less than 10 nm are effective in MRI25, 26 and can be 
synthesized following recently reported methods27-29.  Zhang and collaborators used 
cancer-specific functionalities such as folic acid and chlorotoxin in their MRI 
studies.89, 90  Cancer-recognizing antibodies more readily available than specific 
binding moieties are suggested to be bound on MNPs for their MRI studies.  Cheon 
and collaborators attached cancer-specific antibodies on MNPs in their application for 
MRI.25, 26  However, the functionality for enhancing circulation in blood and 
overcoming biobarriers is absent in their MNP-antibody system.  Attachment of PEGs 
on the surface of MNPs by adding a controlled amount of activated PEG derivative 
such as mPEG-succinimidyl propionate (mPEG-SPA; Nektar, San Carlos, CA) is 
recommended as shown in Figure 6.1.  For the use of intraoperative optical devices, 
dye molecules can be attached, either directly on MNPs or indirectly via the binding 
of dye-labeled antibodies.   
 
  105 
 
 
Figure 6.1 Proposed reactions to build multifunctional magnetic nanoparticles for MR 
imaging.  
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Kim and collaborators2 reported peptide-mediated intracellular uptake of 
MNP-peptide hybrids and identified target proteins inside living cells using 
movement of intracellular MNPs in applied magnetic fields.  They probed the 
movement and localization of MNPs by fluorescence-based confocal microscopy 
study.  Attachment of transducible peptide, TAT-HA2, on MNPs helped the MNP 
conjugates to be taken inside the cells.  For the application in cancer treatment via 
hyperthermia, it is suggested to hybridize MNPs with cancer-specific antibodies, 
TAT-H2, and dye molecules as described in the previous section.  Confocal 
microscopy-based study of hyperthermia will elucidate the effectiveness of the 
suggested methodology.  
 Monitoring expression of cell surface-bound proteins can be a target for future 
study using MNPs hybridized with the protein-specific molecules.  Magnetic field-
assisted separation of MNP-biological cell conjugates will confirm the existence of 
cell surface-expressed proteins.  
 Differential functionalization of SiO2/TiO2 nanoparticles by the sequential 
reaction with organophosphorous compounds and silane reagents can be an effective 
route to the fabrication of multifunctional nanoparticles. The availability of 
phosphorous compounds containing terminal functional groups such as –OH,100, 101 -
SH,148 and –COOH149, 150 and the well-established silane chemistry provide a number 
of ways to attach different functionalities on the mixed nanoparticles.  
Functionalization of SiO2/TiO2 by a surface-specific approach with different reaction 
groups is suggested as shown in Figure 6.2.  This differential functionalization with 
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both –SH and –NH2 functional groups on the surface will increase applicability of the 
mixed nanoparticles. 
 
 
 
Figure 6.2  Suggested scheme of differential functionalization.   
 
Recently, synthesis of metal-metal oxide particles has been reported.3, 12, 37, 38, 
175  Nanosize Au-metal oxide dimers have been made via metal oxide nanoparticle 
assembly at a liquid-liquid interface3 and decomposition of metal oxide precursors on 
Au surfaces12.  Asymmetric binding between metal and metal oxide nanoparticles 
may have advantages over spherical nanoparticles in an attempt to construct 
multifunctional nanoparticles and applications requiring higher complexities and 
lower symmetries.37, 38  The differential functionalization demonstrated in Chapter 4 
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variety of composites of Au-SiO2/TiO2 mixed nanoparticles can be made via selective 
binding of Au nanoparticles on a specific portion of differentially functionalized 
SiO2/TiO2 mixed nanoparticles using affinity of Au nanoparticles to thiolated- and 
amine-functionalized surface.  First, Au nanoparticles can be attached only onto a 
specific surface of the mixed nanoparticles (Figure 6.3).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3  Methodologies to attach noble metal nanoparticles only to TiO2 surfaces 
of SiO2/TiO2 nanoparticles. (a) Generation of Au (Ag) nanoparticles on a TiO2 
surface by a photocatalytic route.  (b) Selective attachment of Au nanoparticles to 
TiO2 via preferential binding of phosphonic acids with thiol (or amine) functional 
group and affinity of Au nanoparticles to TiO2-specific thiol (or amine) functional 
groups.   
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TiO2 is well known for its photocatalytic activity.  Noble metals are deposited 
on TiO2 surface via a photocatalytic route.45-48, 50, 176-179  This property can be applied 
to prepare TiO2-specific generation and binding of Au (Ag) nanoparticles (Figure 
6.3(a)).  The other way to preferentially bind Au nanoparticles is via selective binding 
of phosphonic acids in aqueous environment.  Phosphonic acids with a thiol or an 
amine functional group are first bound selectively on TiO2 surfaces.  Au nanoparticles 
prepared in another reaction can be applied to the thiol (amine) functionalized 
surfaces and are attached to them by Au-thiol group and Au-amine group affinity.   
 It is suggested that Au nanoparticles can be attached selectively on SiO2 
portion of SiO2/TiO2 mixed nanoparticles (Figure 6.4).  TiO2 surfaces are passivated 
by reaction with PPA.   Subsequent silane reaction with APTES renders Au-attracting 
amine functional groups on silica surfaces.  Addition of Au nanoparticles to the 
surface-functionalized particles leads to asymmetric binding of Au to SiO2 portion of 
the mixed nanoparticles.   
 Asymmetric binding of two different size-Au nanoparticles is suggested 
(Figure 6.5).  Preferential binding of Au nanoparticles to the SiO2 surfaces (Figure 
6.3(b)) is followed by passivation of the attached Au surfaces by the reaction with 
thiolated molecules and silanization of the SiO2 surfaces by the reaction with APTES.  
Larger Au nanoparticles are mixed with the functionalized nanocomposite particles 
leading to asymmetric binding of two different size-Au nanoparticles.  This will serve 
as visual evidence of differential functionalization of the mixed nanoparticles.   
Various thiol compounds can be used to react with the attached Au surfaces.  
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Figure 6.4  Selective binding of Au nanoparticles to the SiO2 portion of SiO2/TiO2 
mixed nanoparticles. PPA: phenyl phosphonic acid.
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Figure 6.5 Asymmetric binding of two different size-Au nanoparticles to SiO2/TiO2 
mixed nanoparticles. 
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 Finding a functionality, that binds preferentially to SiO2/Fe2O3 mixed 
nanoparticles, is the next task.  Since Si-O-P bonds are readily hydrolysable, the first 
trial can be to apply organophosphorous compounds to the mixed nanoparticles in an 
aqueous solution.   
The synthesis methodology of Fe3O4-Au dimmers at a liquid-liquid interface 
can be applied to prepare Au- SiO2/Fe2O3 dimers, where Au nanoparticles are 
attached to the Fe2O3 portion by making Fe2+ surface ions as catalytic sites.3, 9  
 
 
 
 
 
 
 
 
 
 
 
Figure 6.6 Synthesis of Au- SiO2/Fe2O3 dimers via nanoparticle assembly at a liquid-
liquid interface.   
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Effects of concentrations of SiO2/γ-Fe2O3 MNP up to 100 mg MNP/L and 
concentrations of divalent ions such as Ca2+, Mg2+, and SO42- on XRS scattering are 
discussed in Appendix C.6.  The nanoparticles used in the XRS study were bare 
unmodified particles.  Additional XRS studies using functionalized MNPs such as 
MNPs coated with a PEG layer and those suggested in Figure 6.6 need to be done to 
see if the functionalized particles are more lipophilic and can penetrate the cellular 
membrane.   
 
  114 
 
Appendices 
 
Appendix A 
Appendix A covers protocols and experimental data related to Chapter 3.  
 
A.1  Protocol for APTES modification of magnetic iron oxide nanoparticles 
1.  Set up a 500 mL-capacity three neck round bottomed (RB) flask with a stirring rod 
combined with a Teflon blade (Chemglass, Vineland, NJ).  Apply vacuum grease 
at the junction between the RB flask and the stirring rod. 
--- Cleaning of the glassware--- 
2.  Clean the glassware with piranha solution (conc H2SO4 and 35% H2O2, 3:1 v/v) in 
the following order. Operate in a chemical hood. 
2a.  Add 150 mL of Con H2SO4 to the RB flask.  
2b.  Add 50 mL of 35% H2O2 to the H2SO4 in the RB flask. 
Note: Be careful because of a large amount of heat generation during this process.   
2c.  Wait for 1 hour. 
2d.  Decant the piranha solution to a waste bottle. Wash thoroughly the glassware 
ten times with 20 mL of fresh double distilled water each time.  
---APTES reaction--- 
3.  Add 45 mL of double distilled water in the RB flask.  
4.  Add 1.5 g of γ-Fe2O3 particles (Alfa Aesar, Ward Hill, MA). 
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5.  Suspend the γ-Fe2O3 particles in aqueous solution with 20 minute sonication in a 
bath sonicator. 
6.  Set up the RB flask with a condenser linked to a nitrogen source. Put the glassware 
in an oil bath on a heating plate. Connect the stirring rod with a mechanical stirrer. 
Turn on water, nitrogen, and heat.  
7.  Add 5 mL APTES drop by drop to the solution while vigorous mechanical stirring. 
8.  Control heat so that the temperature of the oil bath can be maintained at 120 OC. 
9.  Maintain this reflux condition for 3 hours. 
10.  Turn off the heater and cool down the reaction system. 
11.  Decant the reacted suspension of γ-Fe2O3 particles to a 50 mL-capacity 
centrifuge tube. 
12.  Separate the magnetic nanoparticles using a neodymium-iron-boron permanent 
magnet. 
---Washing--- 
13.  Add 20 mL of double distilled water to the separated magnetic particles.  
14.  Suspend and mix the particles for 3 minutes on a vortexer. 
15.  Repeat steps 12-14 twice more. 
16.  Repeat steps 12-14 once. This time use 20 mL of 95% ethanol instead of water in 
step 12. Separate the particles with the permanent magnet and remove the 
supernatant. 
17.  Remove the remnant ethanol as much as possible by centrifugation at 4500 rpm 
for 5 minutes. 
---Drying and storing--- 
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18.  Dry the resulting magnetic nanoparticles overnight in vacuum. 
19.  Store the dried particles in a desiccator until further usage. 
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A.2  Protocol for glutaraldehyde activation   
Glutaraldehyde kit was purchased from Polysciences (Warrington, PA)   
1.  Place 10 mg of APTES-modified iron oxide in a glass vial.    
2.  Add 1 mL of PBS to the vial and sonicate for 10 minutes in a bath sonicator.  
3.  Add 3 mL of 8 % glutaraldehyde in PBS (Polysciences, Warrington, PA) to the 
vial. 
     Note: This step makes the final glutaraldehyde concentration 6 %. 
4.  Mix for 5-6 hours at room temperature on a rocker table, rotary shaker, or any kind 
of shaker which provides end-to-end mixing.  
5.  Discard the supernatant while holding the particles using a magnet.   
6.  Resuspend particles in 2 mL of PBS (Washing step).  
7.  Vortex until the particles are completely dispersed.  
8.  Discard the supernatant while holding the particles using a permanent magnet.   
9.  Repeat steps 6-8 twice more.  
10.  Suspend the particles in a desired amount of PBS.  
      (Ex) 4.0 mL of PBS was added to 10 mg MNPs in the method of Chapter 3.  
11.  Use the glutaraldehyde-activated MNPs right away for immobilization of anti-
mouse IgG.  
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A.3  Protocol for immobilization of Fluorescein-labeled anti-mouse IgG on the MNPs 
1.  Prepare a PBS solution containing anti-mouse IgG at a desired concentration. 
2.  Add 80 µL of 4.0 mL of PBS solution containing 10 mg of glutaraldehyde-
activated MNPs (step A.2.10) to 920 µL of an anti-IgG solution in PBS.  The 
amount of MNPs in 1 mL of the mixture is 0.20 mg. 
3.  Shake at room temperature for 20 hours.  
4.  Separate the MNPs with a permanent magnet. 
5.  Take the supernatant and keep it separate for determination of amount of anti-IgG 
in the supernatant. 
6.  Add 1 mL of PBS (pH 7.4) and vortex briefly. 
7.  Repeat steps 4-6 twice. 
8.  Suspend 0.20 mg of the MNPs in 1.0 mL of PBS and store them in a refrigerator 
until further usage. 
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A.4  Protocol for labeling antibodies with reactive dyes with succinimidyl ester group 
Succinimidyl ester-functionalized dyes (Molecular probes, Eugene, OR) form 
a stable amide bond with amine groups of antibodies such as lysine.   
1.  Dialyze antibody solution containing sodium azide as preservatives for 2 hours in 
PBS solution, using Spectra/Por (Rancho Dominguez, CA) dialysis kit (molecular 
weight cut-off 50,000). 
2.  Dissolve succinimidyl ester-linked dyes in dimethyl sulfoxide (DMSO) right 
before a labeling reaction at 10 mg dye/mL DMSO. 
     (Ex)  Add 1 mg dye to 0.1 mL DMSO.  
3.  Add 0.1 mL sodium bicarbonate buffer (pH 8.3-9.0) for each mL of antibody 
solution, since succinimidyl ester-dyes react with ε-amino groups in a slightly 
basic buffer. 
4.  While stirring an antibody solution, add the reactive dye solution slowly.  Stir the 
mixture of antibody and dye for 1 hour at room temperature in protection from 
light.  
5.  Separate the conjugates from unreacted free dyes in a PBS-equilibrated Sephadex 
G-25 column.  The first excluded fraction to elution is the dye-antibody conjugate.  
6.  Store the dye-antibody conjugates at 4 OC in 2 mM sodium azide as preservative.    
7.  Determine the degree of labeling. 
7a.  Dilute the protein-dye conjugate to approximately 0.1 mg/mL.  Measure the 
absorbance of the protein-dye conjugate at 280 nm and at λmax (λmax of 
Alexa 568 = 578 nm) of the dye. 
7b.  Correct the contribution of the dye in the absorbance at 280 nm. 
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                 Aprotein = A280 – Amax × CF                                                            (A.1) 
        (CF = A280 free dye/Amax free dye; CF is given by the dye vendor)  
7c.  Calculate the protein concentration. 
       1.4: Aprotein = 1 mg/mL : Protein concentration (mg/mL)                        (A.2) 
       This equation is correct for IgG antibodies.  
7d. Calculate the degree of labeling (DOL). 
DOL is defined as the dye concentration in the antibody-dye conjugates 
divided by the antibody concentration in the conjugates. 
       DOL = 
antibody
dye
C
C
                                                                             (A.3) 
The Beer-Lambert Law is given as equation A.4. 
         A =  ε × C × l                                                                               (A.4) 
A: absorbance 
e: the extinction coefficient, cm-1M-1 
C: mole concentration; mol/L 
 l: light pathway length, 1 cm 
 
Combining Equation A.3 with the Beer-Lambert law leads to Equation A.5. 
      DOL = 
antibody
dye
dye
MW
Antibody
cm
A
][
1
max,
×ε
λ
                                                                      (A.5) 
  where [Antibody] = mass concentration of antibody (g/L).  
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   Rearranging Equation A.5 gives Equation A.6. 
             DOL = 
dye
antibodydye
Antibody
MWA
ε×
×
][
,578                                                        (A.6) 
  Because antibody does not have absorbance at 578 nm, A 578, dye is the same 
with A 578, conjugate. Therefore, 
    DOL = 
dye
antibodyconjugate
Antibody
MWA
ε×
×
][
,578                                                    (A.7) 
   where MW antibody : 150-170 kDa,  
              [Antibody]: given by equation A.2, and  
              ε Alexa 568 : 91,300 cm-1M-1.  
 
Therefore a measured absorbance of the mouse IgG-Alexa 568 conjugate at 
578 nm provides DOL from Equation A.7. 
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A.5  Sequestration of Alexa 568-labeled mouse IgGs from solution 
1.  Separate 0.20 mg of MNP-anti-mouse IgG conjugates from solution (A.3.8) with a 
neodymium-iron-boron permanent magnet. 
2.  Add 1.0 mL of PBS containing a desired amount of Alexa 568-labeled mouse IgG.  
3.  Mix for 2-3 hours in room temperature. 
4.  Separate the MNPs using a permanent magnet and discard the supernatant. 
5.  Add 1.0 mL of fresh PBS. 
6.  Vortex briefly. 
7.  Repeat steps 4-6 three times. 
8.  Keep the suspended particles in PBS in a refrigerator for later characterization. 
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A.6  Phosphate buffered saline (PBS; pH 7.4)  
    
NaCl                              9.00 g 
Na2HPO4    0.80 g 
KH2PO4    0.14 g 
dH2O   (distilled water)                    1000 mL  
Adjust pH to 7.4    
 
A.7  Maximum absorbance and emission wavelength of dyes used 
        in Chapter 3 
 
Table A.1 Maximum absorbance/emission wavelength of dyes. 
 
Maximum Absorbance 
Wavelength (nm) 
Maximum. Emission 
Wavelength (nm) 
Fluorescein 495 520 
Alexa Fluor 568 578 603 
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A.8  Spex Fluorolog-3 fluorometer (Dr. Robert Walker’s Laboratory)  
A.8.1 Operation protocol 
1.  Turn on the power switch. 
2.  Turn on the main lamp switch. 
3.  Turn on the SpectACQ computer. 
4.  Turn on the Dell Optiplex computer. 
5.  Turn on the monitor screen. Wait for 15 minutes for warming up. 
6.   Double click “shortcut to datamax_32” icon. 
7.  Click “OK” and then “Yes”. 
8.  Run “visual setup”, the third square icon. 
9.  Click on “sample chamber” in visual set up. 
10.  Click on image. 
11.  Take both polarizers “OUT” and then close window.  
12.  Close polarizer window. 
13.  Click on “run experiment” icon in “instrumental control center”. 
14.  Go to “collect” and click on “experiment”. 
15.  Double click “dtf1.exp”. 
16.  Click on “data file”. 
17.  Choose “1.spc” under file name. 
18.  Go to “visual setup” window. 
19.  Under “options”, choose “units” and change “slits” to “millimeters”.  Click OK. 
20.  In “main experiment” window, click on “slits” and change “excitation” to 0.5 
(mm)   and emission to 0. 
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21.  Click “OK” and “run”. 
22.  Click “Yes”. 
23.  Record wavelength, intensity, date and name in log book. 
24.  Click on “experiment” 
25.  Control slit width. 
  (Ex) Slits: Excitation: 3.00 nm, Emission: 3.00 nm 
26.  Set the excitation wavelength and emission scanning range. 
  (Ex) Fluorescence-labeled anti-mouse IgG: 
   Excitation at 495 nm, emission scan range: 500 – 700 nm 
27.  Save the set up condition as **.exp. 
28.  Load a sample in a quartz cuvette and put it into the Fluorometer. 
29.  Run the sample. 
30.  Save the plot as *.spc file. 
31.  After running all the samples, turn everything off in the reverse order. 
   Note: Wait 15 minutes before turning off power in order to cool down the lamp  
before shut off. 
32.  Turn off the power switch. 
  Note: Make sure to turn off the power switch, since it is easy to forget it after 
waiting for a while. 
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A.8.2 Data processing 
1.  Turn on the Dell Optiplex computer. 
2.  Turn on the monitor screen. 
3.  Double click “shortcut to datamax_32” icon. 
4.  Open “file” and “import/export”.  Click “export” without changing settings.  
     Choose a file(s) to transfer. 
5.  Retrieve through right click, start, and explore. 
6.  Turn off the computer. 
7.  Process the data with a data processing program such as Igor Pro 4.0 
(Wavematrics, Lake Oswego, Oregon). 
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A.9 Hitachi F-4500 fluorescence spectrophotometer (Dr. Lyle Isaacs’ lab) 
1.  Turn on the computer, the monitor and the spectrophotometer. 
2.  Wait for 15 minutes for warming up. 
3.  Click on the spectrophotometer icon. 
4.  Set up a scan condition. 
(Ex) Excitation/Emission slit: 5.0 nm/5.0 nm 
PMT voltage: 950 
Scan speed: 240 nm/min 
5.  Run the scan of antibody-MNP conjugates suspended in PBS (pH 7.4). 
5a.  Fluorescein-labeled anti-mouse IgG on the MNPs: 
Excitation at 480 nm; emission scan: 490- 700 nm 
5b.  Alexa 568-labeled mouse IgG on the MNPs: 
   Excitation at 550 nm; emission scan: 560 – 800 nm 
Note: Alexa 568-mouse IgGs caught by MNP-anti-mouse IgG conjugates 
were excited at 550 nm instead of 578 nm to evade scattering from the MNPs.  
6.  Turn off the computer and the spectrophotometer. 
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A.10  A standard calibration curve for quantification of Fluorescein-labeled anti-
mouse IgG  
A standard calibration curve of Fluorescein-labeled anti-mouse IgG is given in Figure 
A.1. 
 
A.10.1  Method  
-Spex Fluorolog-3 fluorometer in Dr. Robert Walker’s Laboratory 
-Slits: Excitation/Emission: 3.00 nm/3.00 nm 
-Excitation at 495 nm, emission scan range: 500 – 700 nm 
-Maximum emission intensity was measured at 520 nm. 
Figure A.1 Standard calibration curve of fluorescein-labeled anti-mouse IgG. 
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A.11  Washing effect of MNPs after reaction with Fluorescein-labeled anti mouse-
IgG 
 
 
 
 
 
 
 
 
 
Figure A.2  Washing effect of MNPs treated with fluorescein-labeled anti-mouse IgG. 
(a) Bare γ-Fe2O3 nanoparticles (the amount of added anti-mouse IgG = 160 µg/mg 
MNP), (b) APTES-modified and glutaraldehyde-activated γ-Fe2O3 nanoparticles (the 
amount of added anti-mouse IgG = 100 µg/mg MNP). 
 
Figure A.2 shows that three washing steps in Chapter 3 are reasonable for a 
quantitative analysis of anti-mouse IgG binding on the MNPs. 
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A.12  Calculation of anti-mouse IgG binding on MNPs 
MNPs interfere in a direct measurement of fluorescence and tend to settle 
during a fluorescence measurement.  The amount of anti-mouse IgG binding on 
MNPs was measured in an indirect way using the following equation. 
    The amount of bound anti-IgG  
= (Initial quantity of anti-IgG) – (unreacted quantity of anti-IgG)                  (A.8)
  
An example of calculation is given as follows.  24 µL of the anti-mouse IgG 
stock (Invitrogen;  2 µg IgG/µL) was added to a MNP solution. After a reaction 
following the procedure in Appendix A.3, the MNPs were washed four times with 1 
mL of PBS each time.  The supernatant of reacting solution along with washing 
solution was collected.  The volume of the combined supernatant solution was 
measured with a graduated cylinder.  It was 4.95 mL.  After diluting 2.5 times, the 
anti-IgG concentration in the diluted solution was determined to be 1.45 µg anti-
IgG/mL following the procedure of Appendix A.8 and the standard curve in Figure 
A.1.   
 Equation A.8 is rewritten in terms of concentration and volume. 
    The amount of anti-IgG bound on MNPs  
= Cbefore × Vbefore –  dilution factor × Cafter × Vafter                                                              (A.9) 
where Cbefore: the concentration of the anti-IgG stock solution  
            Vbefore:  the added volume of the anti-IgG stock solution 
 dilution factor: 2.5 in this example 
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           Cafter:  the concentration of anti-IgG in supernatants after the reaction  
    Vafter:  the volume of the supernatants after the binding reaction 
Therefore,  
The amount of anti-IgG bound on MNPs  
  = 2 × 24 – (2.5 ×1.45) × 4.95  
    = 30 µg anti-IgG                                                                                      (A.10) 
The amount of MNPs in the solution is 0.20 mg (step 2 of Appendix A.3). Therefore, 
The concentration of anti-IgG bound on MNPs 
= 30 µg anti-IgG/0.20 mg MNP   
= 150 µg anti-IgG/mg MNP                                                                    (A.11) 
150 µg anti-IgG per mg MNPs was calculated to be bound in this way.                                                       
 
  132 
 
A.13 Calculation of MNP-coverage by anti-mouse IgG  
Based upon known antibody molecular dimensions (Y-shape; height = 8.5 nm, 
width = 14.5 nm, thickness = 4.0 nm),132 and the surface area of the MNPs being 42.2 
m2/g measured by BET method, the MNP-surface coverage by anti-mouse IgG is 
calculated below.  If the anti-IgG has the binding conformation on the side as in 
Figure A.3, the per-molecule “footprint” should be 34 nm2.  
 
 
 
 
 
Figure A.3  A schematic configuration of anti-IgG binding on the MNP surface.  The 
footprint is 34 nm2 in this case. 
 
  Under the assumption of close packing and all surface bound anti-IgGs taking 
the same conformation as in Figure A.3,  division of the particle surface area with the 
per-molecule footprint provides a maximum number of anti-IgG bound on the MNPs 
as in Equation A.12. 
                                 2
2
34
2.42
nm
g
m
  = 
g
18102.1 ×                                                     (A.12) 
The number of anti-IgG molecules is converted to a number of moles number using 
Avogadro’s number. 
4.0 nm
8.5 nm
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g
18102.1 ×  =  2.1 × 10-6 mole anti-IgG/g MNP                                      (A.13) 
Using the molar weight of anti-IgG of 160 kDa,  
          2.1 × 10-6 mole anti-IgG/g MNP          
       = 3.3 × 10-1 g anti-IgG/g MNP 
       = 3.3 × 102 µg anti-IgG/mg MNP                                                        (A.14) 
Division of the saturated anti-IgG binding in the experiment, 122 µg anti-
IgG/mg MNP, with the maximum theoretical value in Equation A.14 provides a 
MNP-surface coverage by anti-mouse IgG.  
         Max. experimental saturated anti-IgG binding/Max. theoretical anti-IgG binding   
            = (1.22 × 102) / (3.3 × 102)  
            = 0.36                                                                                                      (A.15) 
  Therefore, a MNP surface coverage by the anti-mouse IgG is 36% under the 
assumptions.  Table 8.2 represents typical configurations of anti-IgGs on the MNP 
surface and the MNP-surface coverages in each case. 
Table A.2 Surface coverage of MNPs as a function of the anti-IgG orientation. 
 
 
 
 
 
 
34                  58                   120      
36                  61                   130
Anti-IgG
orientation
Case I Case II Case III
Saturated surface
coverage (%)
Foot print area
(nm2) 
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A.14  Calculation of the number of anti-IgGs bound on MNPs 
at saturation 
Under the assumption that all MNPs have the same size of 32 nm, the number 
of anti-IgGs bound per MNP at saturation can be calculated as below. 
The saturated binding of anti-mouse IgG is 122 µg anti-IgG/mg MNP in 
Chapter 3.  Using the molecular weight of antibody of approx..160 kDa and 
Avogadro’s number, the amount of anti-IgG is converted to a number of anti-IgGs. 
122 µg anti-IgG = 4.59 × 1014 anti-IgG       (A.16) 
The measured surface area (42.2 m2/g MNP) and the MNP-diameter (32 nm) are used 
to convert 1 mg of MNPs to a number of MNPs. 
1 mg MNP = 1.3 ×1013 MNP                       (A.17) 
Therefore, the saturated binding of anti-IgGs is converted to a number of anti-IgGs 
per MNP. 
        122 µg anti-IgG/mg MNP 
     = 4.59 × 1014 anti-IgG/ 1.3 ×1013 MNP 
     = 35 anti-IgG/MNP                                      (A.18) 
Therefore, 35 anti-IgGs are bound per average-size MNP (diameter = 32 nm) in 
saturated binding.  
  135 
 
A.15 TEM images and particle size distributions of iron oxide MNPs 
 
 
 
 
 
Figure A.4   Transmission electron microscopy images for bare γ-Fe2O3 nanoparticles 
(A), APTES modified nanoparticles (B), and anti-mouse IgG modified nanoparticles 
(C) were acquired and are shown below. 
 
  
100 nm
100 nm
100 nm
A
C
B
Particles were suspended in PBS (pH 
7.4) before being loaded on a TEM grid
A: bare γ-Fe2O3
B: APTES-modified γ-Fe2O3
C: γ-Fe2O3 immobilized with anti-
mouse IgG
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Figure A.5  Particle size distribution of bare γ-Fe2O3 nanoparticles. Particle size 
distributions were created from the TEM images and were invariant with surface 
preparation.  The size distribution constructed from TEM images of bare 
nanoparticles is shown above. 
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Appendix B 
Appendix B contains protocols for sample preparations in Chapter 4.  
B.1  Protocol for phosphonic acid modification 
1.  Mix methanol and double distilled water with 4:1 ratio.    
2.  Add phenyl phosphonic acid (PPA) to be 4 mM in the mixed solvent.  
(Ex) PPA 0.632 g in 1.0 L of the mixed solvent  
3.  Adjust the pH of the PPA solution to be 4. 
4.  Add metal oxide nanoparticles at a concentration of 1.0 mg per 1.0 mL of the 
solvent. 
5.  Stir in room temperature for 15 hours. 
6.  Centrifuge the reacted nanoparticles.  
     (Ex) Centrifuge for 10 min at 10,000 × g (approx. 7000 rpm) using a 300 mL-
capacity Nalgene (Rochester, NY) tube in a centrifuge (Dr. Nam Sun Wang’s lab). 
     Note: Be careful not to break the centrifuge tube.  Centrifuge tubes tend to be 
broken by either loading too much sample in a centrifuge tube or setting up too 
high centrifugation speed.  
7.  Add 5-10 mL of pure mixed solvent (Methanaol:Water = 4:1 v/v) not containing 
PPA.  Resuspend the centrifuge particles by vortexing.  
8.  Transfer the particle suspension in 1.5 mL-centrifuge tubes.   
9.  Centrifuge for 4 minutes at 13,400 rpm in a centrifuge (Minispin, Eppendorf, 
Hamburg, Germany; Dr. Doug English’s Lab).  
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10.  Discard the supernatant. 
11.  Add 1 mL of the pure mixed solvent. 
12.  Vortex briefly to suspend the particles.  
13.  Repeat steps 9-12 seven times. 
14.  Discard the supernatant.  Dry the particles in a vacuum oven (1 mbar, 120 OC) for 
15 hours. 
15.  Store the dried particles in a desiccator.  
        Characterize the particles with XPS.  
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B.2  Protocol for reaction with N,O-bis(trimethylsilyl)trifluoroacetamide (BSTFA) 
1.  Add metal oxide nanoparticles in a RB flask.  
2.  Purge air in the flask with nitrogen. 
3.  Add dry toluene to the particles at a concentration of 10 mg/mL.  
4.  Sonicate the particles in a bath sonicator for 10 minutes. 
5.  Add BSTFA in one tenth volume of dry toluene. 
(Ex) Add 0.2 mL BSTFA to particle-suspended 2 mL dry toluene. 
6.  Stir for 2 hours. 
7.   Transfer the particle suspension in 1.5 mL-centrifuge tubes.   
8.  Centrifuge for 4 minutes at 13,400 rpm in a centrifuge (Minispin, Eppendorf, 
Hamburg, Germany; Dr. Doug English’s Lab).  
10.  Discard the supernatant. 
11.  Add 1 mL of the pure dry toluene. 
12.  Vortex briefly to suspend the particles.  
13.  Repeat steps 9-12 four times. 
14.  Discard the supernatant.  Dry the particles in a vacuum oven (1 mbar, 120 OC) 
overnight. 
15.  Store the dried particles in a desiccator.  
        Characterize the particles with XPS.  
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Appendix C 
Appendix C describes protocols in Chapters 5.  Operate in a Laminar flow 
bench to maintain sterility. 
C.1 Cell culture medium compositions 
C.1.1  Ampicillin 
Ampicillin is an antibiotics used to keep sterility in the cell culture.  E. coli 105 
harboring pBR 322 (ApR) is ampicillin-resistant.  The final concentration of 
ampicillin in a typical cell culture medium in Chapters 5 and 6 was 100 µg 
ampicillin/mL of medium.  One thousand time concentrated (1000 X; 100 mg/mL) 
ampicillin stock solution is prepared for afterward applications.  
 
1.  Dissolve 2.5 g of ampicillin powder in 25 mL of autoclaved distilled water.  
2.  Sterilize the ampicillin solution by filtering through a 0.20 µm pore size filter 
(Millipore, Billerica, MA).  
Note: Ampicllin is heat sensitive. Do not sterilize an ampicllin solution by 
autoclaving.  
3.  Divide the 25 mL filter-sterilized ampicillin solution into 1 mL aliquots.  Put each 
aliquot in an autoclaved 1.5 mL-capacity centrifuge tube.  
4.  Label the ampicillin aliquots in the centrifuge tubes. (Ex) 1000X Ap 
5.  Store the ampicillin aliquots in a -20 OC refrigerator until further usage.  
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C.1.2  Luria Bertani (LB) medium  
Bacto tryptone                 10 g 
Bacto yeast extract            5 g 
NaCl                                10 g 
dH2O (distilled water)     1 liter volume 
 
1.  Mix all ingredients together and adjust pH to 7.0 with 5 N NaOH (approx. 0.4 
mL/liter). 
2.  Autoclave for 20 min. 
3.  After cooling down the autoclaved medium, add 1 mL of 1000X antibiotics 
(ampicillin) solution.  
 
For agar plates,  
1.  In addition to the ingredients mentioned for liquid LB medium, add 15 g (for a 
harder agar plate, 20 g) agar to the liquid LB medium.  
2.  Autoclave for 20 minutes.  Keep in mind to leave a magnetic bar in the medium. 
3.  Cool down the medium to about 45 OC. Then, add 1 mL of 1000X ampicillin 
solution. 
4.  Mix the antibiotics-added LB medium for a minute on a magnetic stirring plate. 
5.  Pour out the LB-agar medium to a 10 cm diameter petri dish. You can make about 
forty agar plates using 1 L LB-agar medium. 
6.  Let the LB-agar medium in petri dishes cooled down and solidified overnight. 
7.  Store the solidified agar plates in a refrigerator until further usage.  
  142 
 
C.1.3  M9 medium 
Medium composition  
Sterile 10X Salt*                        100 mL 
20% glucose                                  20 mL 
0.01 M CaCl2a                              10 mL 
0.1 M MgSO4a                             10 mL 
20% Casamino acids                     20 mL 
dH2Oa                                          840 mL 
Note:  Autoclave each ingredients separately, since sediments may form when they 
are mixed together and autoclaved. Mix the ingredients to make M9 medium 
after cooling down the separately-autoclaved ingredients.  
aNote: These ingredients may be changed in accordance with the different kind of M9 
medium in Table 6.1 of Chapter 6.  
 
* Salt Mix  10X 
Na2HPO4                              70 g 
or (Na2HPO4·7H2O)           (132 g) 
KH2PO4                                30 g 
NaCl                                        5 g 
NH4Cl                                   10 g 
H2O                                   1000 mL  
 
  143 
 
C.1.4  Preparation of a MNP solution 
 
1.  Add a desired amount of MNPs in a glass vial. Add distilled water. 
2.  Sonicate the particles in the solution using a tip sonicator (Dr. Nam Sun Wang’s 
lab) or a bath sonicator (Dr. Doug English’s lab or Dr. Lyle Isaacs’ lab) for several 
minutes.  
3.  Autoclave for 20 minutes. 
4.  Add the autoclaved MNP solution to cell culture medium (M9 medium) between 
step 4 and 5 in Appendix C.2 (E. coli cell culture).  
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C.2  E. coli cell culture 
 
1 mL of 30% glycerol stock of E. coli JM 105 harboring pBR 322 (ApR) was a 
gift from the laboratory of Dr. William Bentley at the Department of Chemical and 
Biomolecular Engineering, University of Maryland.  Divide the 1 mL glycerol stock 
into ten 100 mL aliquots and store the aliquots in a -80 OC refrigerator.  Thaw and use 
one aliquot each time for a series of X-ray scattering experiments.   
 
1.  Sterilize a wire loop in a flame for about 10 seconds.  Cool down the hot wire in 
the air.  Dip the loop into the glycerol stock.  Streak the loop on solid agar of LB 
medium including 100 µg ampicillin/L in a petri dish (diameter = 10 cm).  
Note: Record the date of incubation, E. coli strain name, and the researcher name 
on the bottom of the petri dish near the rim. 
2.   Put the agar plate upside down in a 37 OC incubator.  Let the E. coli grow for a 
day or two in the incubator.  Store the agar plate in a refrigerator after the 
incubation.  E. coli on an agar plate are viable up to a few weeks in a refrigerator.  
It is recommended to use E. coli on an agar plate within one week from 
preparation time.   
   Note: You can transfer E. coli to another fresh agar plate by taking a colony of E. 
coli with a wire loop and streaking it on the fresh agar plate. 
3.    Take a colony with a flame-sterilized wire loop from an agar plate and inoculate 
it to a 5 mL LB medium in a 15 mL-capacity centrifuge tube.  
4.   Incubate the inoculated LB medium at 100 rpm for 6 hours in a 37 OC incubator. 
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5.  Inoculate 250 mL M9 medium in a 500 mL-capacity flask with the grown E. coli 
(5 mL) in a centrifuge tube.   
6.  Incubate the inoculated 250 mL M9 medium at 100 rpm for 12 hours in a 37 OC 
incubator. 
7.  Decant the grown E. coli to 500 mL or 1000 mL-capacity three necked flask. 
8.  Start an X-ray scattering experiment. 
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C.3  Continuous E. coli growth and in situ X-ray scattering 
 
Continuous E. coli culture is used for in situ X-ray scattering.  A detailed 
procedure is described as follows. 
 
1.  Apply vacuum grease at the junction between the RB flask and the stirring rod to 
prevent overheating by shear force during stirring. 
2.  Autoclave all the equipments including a 500 mL-capacity three neck RB flask, a 
glass vial for X-ray scattering, tubings, and an air filter. 
3.  Set up all the equipment for continuous growth of E. coli and in situ X-ray 
scattering.  Check the inlet and outlet pump flow rate to be the same at 
approximately 100 mL per hour.  
4.  Check the air flow rate to be approx. 3 vvm (vessel volume per minute; 3 vvm = 
750 mL per minute) using a bubble flowmeter. 
5.  Set up a motor for stirring and a water bath for keeping 37 OC during the E. coli 
culture. 
6.  Decant E. coli grown in 250 mL M9 medium to the three neck RB flask. 
7.  Start continuous growth of E. coli and in situ X-ray scattering. 
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C.4  Washout condition in continuous culture of E. coli 
 
A steady state CSTR (continuous-flow stirred tank reactor) material balance is 
given as equation C.1.116  
xDDx f )( µ−=                                       (C.1) 
where, D = the dilution rate, F/VR 
                 F = volumetric flow rate of feed and effluent liquid streams 
            VR = total volume of culture within the reactor 
            µ = specific grow rate of the cells  
            x = mass concentration of the cells within the reactor 
            xf = mass concentration of the cells in the feed 
 
The prepared feed stream is a sterile cell growth medium, so that xf  = 0.  
Non-zero cell concentration can be maintained only when, 
    D = µ                                           (C.2)  
Equation C.2 reveals that the specific cell growth rate is equal to the dilution 
rate in a steady state CSTR condition.  Equation C.2 also displays that the dilution 
rate should not exceed the maximum specific cell growth rate. 
The maximum specific cell growth rate was determined in a batch culture of E. 
coli in M9 medium.  The growth curve is given in Figure C.1. 
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Figure C.1  Growth curve of E. coli in M9 medium in a batch culture.  OD600 is 
optical density of cells at 600 nm.  
 
The specific growth rate (µ) is defined as follows. 
dt
xd
dt
dx
x
ln1 ==µ                       (C.3) 
where x = mass concentration of the cells within the reactor 
 
The application of Equation C.3 to the growth curve results in Figure C.2.  
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Figure C.2  Specific growth rate as a function of the E. coli culture time. 
 
The maximum specific growth rate from Figure C.3 is 0.90 hr-1.  The 
maximum dilution rate is the same with 0.90 hr-1 in accordance to Equation C.2.  
Considering the definition of the dilution rate and the total volume of culture in the 
reactor of 250 mL, the maximum dilution rate 0.90 hr-1 corresponds to the maximum 
flow rate of 225 mL/hr.  This analysis displays that the continuous growth of E. coli 
should be operated within 225 mL/hr of the volumetric flow rate.  The procedures 
described in operations of Chapter 5 used a volumetric flow rate of 100 mL per hour 
within the limit of 225 mL/hr.  
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C.4  X-ray scattering 
C.4.1 Bragg’s Law 
 
 
Figure C.3  Derivation of Bragg’s law for X-ray scattering.180 
 
A,B: planes of a crystal structure 
d :  d-spacing, the perpendicular spacing between two adjacent planes of a crystal 
structure. 
θ :  incident angle of the X-rays, same as the reflection angle of the X-rays 
xy:  distance between x and y 
yz:  distance between y and z 
xyz: added value of xy and yz 
1, 2:  incident beams of the X-rays 
1’, 2’: reflected beams of the X-rays 
x
y
z
d
θ θ
θ
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2 2'
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Some of the X-rays are reflected from the plane A at the same angle of reflection with 
the angle of incidence, θ.  The rest are reflected from the adjacent plane, B.  A 
constructive interference between the two reflected beams occurs if and only if the 
following equations are satisfied.  From Figure C.3 
xy = yz = d sin θ                                                                                     (C.4) 
where  d: d-spacing, the perpendicular spacing between two adjacent planes of a 
crystal structure.   
            θ: incident angle of the X-rays 
Thus, 
xyz = 2d sin θ                                                                                         (C.5) 
For a constructive interference,  
xyz = nλ  (∵ n = 1, 2, 3 …)                                                                   (C.6) 
where λ: wavelength of the X-rays, 1.5418 Å in Kα radiation 
Therefore, 
 nλ = 2d sin θ                                                                                            (C.7) 
Customarily, n is set to one.  So, Bragg’s Law is given in the final form as such: 
 λ = 2d sin θ                                                                                              (C.8) 
The q vector is often used in description of X-ray scattering results instead of 
the incident angle θ. The q vector has an inverse relationship with the d-spacing 
according to the following definition.   
  λ
θππ sin42 ==
d
q                                                                                      (C.9) 
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Rigaku in Room 2219, James Patterson Building (Dr.  Luz Martínez-Miranda) 
Check the power of X-rays from the control panel and record the condition and time 
on a Log book.  
(Ex)  Nov 18 2004       50 kV  100 mA     0.502 mPa 
 
C.4.1 Increasing and decreasing the X-ray power 
When you increase the power to the operation power in Chapters 5 and 6 of 
60 kV and 150 mA, follow these steps.  When you decrease the power, you can 
follow the reverse way. 
 
20 kV  10 mA    5 min 
30 kV  10 mA    5 min 
30 kV  50 mA    5 min 
30 kV 100 mA   5 min 
40 kV 100 mA   5 min 
50 kV 100 mA   5 min 
60 kV 100 mA   5 min 
60 kV 150 mA   5 min 
 
Note: Make sure the pressure gauge in the control panel does not exceed 0.11 mPa.  
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C.4.2 Calibration 
 
X-ray machine is calibrated using silicon standard (peak at 2θ = 28.4O).  
Useful commands:  
ctrl-c = strop scanning  
resume=resume scanning 
 
Calibration example 
(Ex) a2scan tth 25 30 phi 12.5 15 50 20 
Note: tth = two theta scan 
          25 30 = scan range of two theta  
          phi = phi scan 
          12.5 15 = scan range of phi, half of the two theta scan range 
          50 = number of data points in the scan range 
          20 = time (second) taken for each data acquisition 
 
If a peak is found other than at 2θ = 28.4O, correct the X-ray machine. 
(Ex) When a peak was found at at 2θ = 27.9O,  
                mv tth 27.9 
                set tth 28.4 
         Note:  mv tth 27.9 = move the two theta arm to 27.9O 
                           set tth 28.4 = set the present two theta value as 28.4O 
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C.4.3  Scanning protocol 
 
1.  Close the shutter of the X-ray control panel (Red light of the shutter control panel 
is OFF now).   
Note: When you open the door of the X-ray room without closing the shutter, X-
rays will be shut down automatically. 
2.  Open the door of the X-ray room and go inside. 
3.  Adjust the sample loading plate all the way down. 
4.  Load the sample holder in the sample loading plate.  
5.  Load the permanent magnets if necessary. 
      Adjust the distance between the permanent magnets by inserting an aluminum bar 
which has a thickness corresponding to a specific magnetic field strength.     
6.  Load the vial connected with the tubing inside the sample holder. 
7.  Start pumping E. coli culture in and out from the sample vial.   
8.  Wait for approximately 20 minutes until a steady state is reached. 
9.  Go out of the X-ray room and shut the door of the X-ray operation room. 
10.  Open the shutter of the X-ray control panel (Red light of the shutter control panel 
is ON now). 
11.  Name the file you are about to scan, so that you can recognize it easily later. 
(Ex) newfile SiFe40_0mT-CaMg_120804 
  Note: SiFe40: 40 mg of SiO2/Fe2O3 per L of M9 medium 
            0 mT: magnetic field strength of 0 mT 
               CaMg: Ca and Mg are doubled in M9 medium 
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              120804: running date is Dec 18 2004 
12.  Run the scan. 
(Ex) a2scan tth 3.0 12.0 phi 1.5 6.0 90 40 
   Note: tth = two theta scan 
             3.0 12.0 = scan range of two theta  
                  phi = phi scan 
                 1.5 6.0 = scan range of phi, half of the two theta scan range 
                 90 = number of data points in the scan range 
                 40 = time (second) taken for each data acquisition 
13.  Record the name of the file and the scanning condition on a logbook. 
14.  When one run is finished, repeat steps 1-2. If necessary, adjust the magnetic field 
strength by changing the distance between the two magnets in the sample holder. 
Repeat Steps 8-12. 
15. When all the scans are finished, clean the X-ray area.  Bring the X-ray power all 
the down to 20 kV and 10 mA following the order in Appendix C.4.1. 
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C.4.4 X-ray scattering data processing 
1.  Click open FTP. 
2.  In session properties window, type in “jmpatt-209.umd.edu” in Host name/address, 
“guest” in user ID, and a password.  Click “OK”. 
3.   Enter into the user’s directory. 
4.  Transfer a file(s) to the user’s own computer. 
5.  Open Origin 6.0. 
6.  File > Import > Single ASCII 
7.  Import a file(s) into Origin 6.0 by choosing the file(s). 
8.  In the data file, the first column contains two theta value and the last column 
includes. 
     X-ray scattering intensity.  Neglect the other columns. 
     Copy the first column and the last column to a new data sheet. 
9.  Two theta values can be converted to q values as follows. 
9a.  Change the name of two theta column head to “tth” 
9b.  Choose a vacant column. 
9c.  Column > Set column values 
9d.  Type in “2*pi*2*sin(pi/180*col(tth)/2)/1.54”,  
 since λ
θππ sin42 ==
d
q , λ = 1.54 Å, and two theta values in degree needs to be 
converted to radian values for calculation of sin θ.  
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 10.  Choose two columns, either tth column & X-ray scattering data column or q 
column & X-ray scattering data column.  Make a graph.  Add another graph to 
the graph if needed.   
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C.5 Growth studies on E. coli after exposure to the X-rays                                             
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure C.4  Comparison of growth curves of E. coli in batch cultures in LB medium. 
The seeds were sampled from different continuous culture conditions; ■: Neither X-
rays nor magnetic fields were applied, ∆: only X-rays were applied, and ○: X-rays 
and 423 mT of magnetic field strength were applied. Magnetic nanoparticles were not 
added to the continuous cultures from which the seeds were taken. 
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Figure C.5  Comparison of growth curves of E. coli in batch cultures in LB medium. 
The seeds were sampled from different continuous culture conditions: ■: Neither X-
rays nor magnetic fields were applied, ∆: only X-rays were applied, and ○: X-rays 
and 423 mT of magnetic field strength were applied. 20 mg/l of SiO2/γ-Fe2O3 
particles was added to the continuous cultures, from which the seeds were taken. 
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C.6  X-ray scattering study of the interactions between magnetic nanoparticles and 
living cell membranes: Effect of concentrations of magnetic nanoparticles and 
divalent salt ions 
 
Chapter 5 describes XRS results for 0 and 40 mg MNP/L concentrations as a 
function of applied magnetic field strengths.  One concentration of MNP, 40 mg 
MNP/L, was used in the XRS works reported in Chapter 5 to see the role of the 
presence of MNPs in an E. coli culture. Therefore, there is a need to investigate the 
effects of other MNP concentrations on the XRS results.  In addition to 0 and 40 mg 
MNP/L, MNP concentrations of 20 and 100 mg MNP/L were examined to see the 
effects of particle concentrations on XRS-detected peaks. 
Divalent ions in M9 medium such as Ca2+, Mg2+, and SO42- have a large effect 
on ionic strength of the medium, and thus on particle agglomerations and cell 
membranes.  Three sets of divalent concentration were used in order to see the effects 
of the divalent ion concentrations on XRS peaks (Table C.1).  The M9 medium used 
in Chapter 5 was M9 type II in Table C.1.  Figures C.5, C.6, and C.7 display 
representative XRS results at different MNP concentrations up to 100 mg MNP/L. 
XRS results at different MNP concentrations were shown on the same graph with the 
same scale for comparisons.  XRS peak positions are shown in Table C.2, C.3, and 
C.4.  
  M9 type I medium did not show a peak at around 0.52 Å-1 at MNP 
concentrations of 0 and 20 mg MNP/L as shown in Figure C.5.  
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Table C.1 Medium composition of three types of M9 media used in XRS studies 
 
 
 
Type I 
(mL) 
 
Type II 
(mL) 
 
Type III 
(mL) 
sterile 10X salt 100 100 100 
20% glucose 20 20 20 
0.01 M CaCl2 10 20 20 
0.1 M MgCl2 10 20 0 
0.1 M MgSO4 0 0 20 
20% casamino acids 20 20 20 
distilled H2O 840 820 820 
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Figure C.6  XRS data of M9 medium type I as a function of MNP concentration up to 
100 mg/L. 
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Table C.2 Peak positions of XRS data of M9 medium type I as a function of magnetic 
field strength and MNP concentration. 
 
 
 
 
 
 
                 
q (Å-1) 
 
 0 mg/L 20 mg/L 40 mg/L 100 mg/L 
0 mT N/A N/A 0.49 0.45 
227 mT N/A N/A 0.49 0.45 
298 mT N/A N/A 0.49 0.45 
362 mT N/A N/A 0.49 0.425 
423 mT N/A N/A N/A N/A 
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XRS peaks at around 0.49 Å-1 appeared in the presence of MNPs at 40 mg MNP/L.  
The peaks grew bigger in intensity and were shifted to the smaller side of q at 100 mg 
MNP/L.   
            M9 type II medium displays XRS results as a function of the concentrations of 
MNPs including the results reported in Chapter 5.  The peak positions at 0.52 Å-1 at 0 
mg MNP/L were not shifted in the presence of MNPs at 20 mg MNP/L.  40 mg 
MNP/L caused the sharp peak shifted to the lower side of q.  Basically, 100 mg 
MNP/L concentration of MNPs showed the same peak positions with XRS results at 
40 mg MNP/L.  
Figure C.7 shows XRS results for MNPs in M9 type III medium.  Distinct 
peaks were detected even at 0 mg MNP/L.  At 0 mg MNP/L, the sharp peak positions 
were shifted from 0.52 Å-1 in M9 type II to 0.46 Å-1 in M9 type III in the applied 
magnetic field strengths of 0, 227, and 298 mT.  362 mT of applied magnetic field 
strength shifted the sharp peak to 0.43 Å-1, whereas no peak shift was observed in M9 
type I and M9 type II at 362 mT and at 0 mg MNP/L.  XRS data at 20 mg MNP/L 
showed almost same peak positions with the case when no MNPs are present in the 
cell culture.  When 40 mg MNP/L was present in the cell culture medium, the XRS 
peaks grew both in intensities and peak widths.  The sharp peaks at 0, 227, and 298 
mT were shifted to 0.40 Å-1, while 362 mT showed the peak at 0.37 Å-1.  
Interestingly, 100 mg MNP/L of MNP concentration shifted back the sharp peak 
positions to the higher side of q.  This may be explained by the highest ionic strength 
of the M9 type III and the presence of MNPs at the highest concentration
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Figure C.7  XRS data of M9 medium type II as a function of MNP concentration up 
to 100 mg/L. 
0.3 0.4 0.5 0.6 0.7 0.8
100 mg MNP/l
40 mg MNP/l
20 mg MNP/l
   0 mT
 227 mT
 298 mT
 362 mT
 423 mT
0 mg MNP/l
In
te
ns
ity
 (a
.u
.)
q (Å-1)
In
te
ns
ity
 (a
.u
.)
  166 
 
Table C.3 Peak positions of XRS data of M9 medium type II as a function of 
magnetic field strength and MNP concentration. 
 
 
                 
q (Å-1) 
 
 0 mg/L 20 mg/L 40 mg/L 100 mg/L 
0 mT 0.528 0.52 0.485 0.49 
227 mT 0.528 0.52 0.485 0.49 
298 mT 0.528 0.52 
0.485 
0.481 
0.49 
362 mT 0.528 0.52 
0.485 
0.459 
N/A 
0.475 
 
423 mT N/A N/A N/A N/A 
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Figure C.8  XRS data of M9 medium type III as a function of MNP concentration up 
to 100 mg/L. 
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Table C.4 Peak positions of XRS data of M9 medium type III as a function of 
magnetic field strength and MNP concentration. 
 
                 
q (Å-1) 
 
 0 mg/L 20 mg/L 40 mg/L 100 mg/L 
0 mT 
0.47 
0.46 
0.47 
0.46 
0.39 
0.399 
0.45 
227 mT 
0.47 
0.46 
0.47 
0.46 
0.39 0.45 
298 mT 
0.47 
0.46 
0.47 
0.46 
0.39 0.45 
362 mT 
0.43 
0.43 
0.43 
0.43 
0.375 
0.385 
0.365 
0.370 
0.40 
0.42 
423 mT N/A N/A N/A N/A 
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Particle agglomeration arising from high ionic strength environment did likely induce 
the shift-back effect at 100 mg MNP/L.  Figure C.8 shows d spacing as a function of 
magnetic field strength at different MNP concentrations.   
 Distinctive peak shifts of the sharp peak were observed at 362 mT.  The sharp 
peak positions at 0 and 362 mT are shown in Figure C.9 to demonstrate M9 medium 
type-dependent shifts of the sharp peak at 362 mT.  Doubling the amount of Ca2+ and 
Mg2+ in M9 medium shifted the d spacing to the smaller side (Figure C.9 (a)).  The 
presence of SO42- in cell culture medium led to an increased d spacing (Figure C.9 
(b)).   
The diffuse peak at 0.61 Å-1 did not show a peak shift in M9 type I and II, 
except the case of 100 mg MNP/L in M9 type I at which the peak was shifted to 0.64.  
The presence of SO42- caused the diffuse peak shifted to 0.67 Å-1.    
In this Appendix, the effects of MNP concentrations up to 100 mg/L and 
divalent ion concentrations on XRS results are shown.  In M9 type I, the sharp peak 
was not present at 0 and 20 mg MNP/L and began to appear at 40 mg MNP/L.  The 
peaks were shifted to the lower side of q at 100 mg/L.  In M9 type II, 40 mg/L is a 
critical concentration, at which the sharp peak was shifted to the lower side of q and 
additional presence of MNPs did not change the peak position further.  In M9 type 
III, the sharp peak position was shifted to the lower side of q at 40 mg/L and was 
shifted back to the higher side of q with the increase of the MNP concentration to 100 
mg/L.  This phenomenon was likely related to the presence of high ionic 
concentration in the cell culture medium.  As shown in Figure C.8, the difference of 
the XRS-determined d spacing between at 40 mg MNP/L and at 100 mg MNP/L is 
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dependent upon the ionic strength of cell culture medium.  The d spacing was 
increased when the MNP concentration was increased from 40 to 100 mg MNP/L in 
M9 type I medium with low ionic strength.  In M9 medium type II with middle ionic 
strength, the d spacing was almost identical between at 40 mg/L and at 100 mg/L.  
The presence of the high ionic strength of M9 medium type III led to a decrease in the 
d spacing when the MNP concentration was increased from 40 to 100 mg/L.   
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Figure C.9  d spacing (Å) as a function of applied magnetic field strengths at different 
MNP concentrations.  (a) M9 type I, (b) M9 type II, (c) M9 type III.
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Figure C.10  d spacing (Å) as a function of MNP concentration in the applied 
magnetic field strength of 0 and 362 mT. (a) Effect of concentrations of cationic 
divalent ions, Ca2+ and Mg2+,  (b) effect of anionic divalent ion, SO42-.   
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